CINXE.COM

Neuroferritinopathy - Wikipedia

<!DOCTYPE html> <html class="client-nojs skin-theme-clientpref-day mf-expand-sections-clientpref-0 mf-font-size-clientpref-small mw-mf-amc-clientpref-0" lang="en" dir="ltr"> <head> <meta charset="UTF-8"> <title>Neuroferritinopathy - Wikipedia</title> <script>(function(){var className="client-js skin-theme-clientpref-day mf-expand-sections-clientpref-0 mf-font-size-clientpref-small mw-mf-amc-clientpref-0";var cookie=document.cookie.match(/(?:^|; )enwikimwclientpreferences=([^;]+)/);if(cookie){cookie[1].split('%2C').forEach(function(pref){className=className.replace(new RegExp('(^| )'+pref.replace(/-clientpref-\w+$|[^\w-]+/g,'')+'-clientpref-\\w+( |$)'),'$1'+pref+'$2');});}document.documentElement.className=className;}());RLCONF={"wgBreakFrames":false,"wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgRequestId":"7b70fa1a-173c-4524-b2a5-c8380147a59e","wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"Neuroferritinopathy","wgTitle":"Neuroferritinopathy","wgCurRevisionId":1254724998,"wgRevisionId":1254724998,"wgArticleId": 24373367,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgPageViewLanguage":"en","wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgRelevantPageName":"Neuroferritinopathy","wgRelevantArticleId":24373367,"wgIsProbablyEditable":true,"wgRelevantPageIsProbablyEditable":true,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgRedirectedFrom":"Adult-onset_basal_ganglia_disease","wgNoticeProject":"wikipedia","wgCiteReferencePreviewsActive":false,"wgFlaggedRevsParams":{"tags":{"status":{"levels":1}}},"wgMediaViewerOnClick":true,"wgMediaViewerEnabledByDefault":true,"wgPopupsFlags":0,"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","pageVariantFallbacks":"en"},"wgMFMode":"stable","wgMFAmc":false,"wgMFAmcOutreachActive":false,"wgMFAmcOutreachUserEligible":false,"wgMFLazyLoadImages":true,"wgMFEditNoticesFeatureConflict":false,"wgMFDisplayWikibaseDescriptions":{"search":true,"watchlist":true,"tagline":false,"nearby":true} ,"wgMFIsSupportedEditRequest":true,"wgMFScriptPath":"","wgWMESchemaEditAttemptStepOversample":false,"wgWMEPageLength":20000,"wgInternalRedirectTargetUrl":"/wiki/Neuroferritinopathy","wgRelatedArticlesCompat":[],"wgEditSubmitButtonLabelPublish":true,"wgSectionTranslationMissingLanguages":[{"lang":"ace","autonym":"Acèh","dir":"ltr"},{"lang":"ady","autonym":"адыгабзэ","dir":"ltr"},{"lang":"alt","autonym":"алтай тил","dir":"ltr"},{"lang":"am","autonym":"አማርኛ","dir":"ltr"},{"lang":"ami","autonym":"Pangcah","dir":"ltr"},{"lang":"an","autonym":"aragonés","dir":"ltr"},{"lang":"ang","autonym":"Ænglisc","dir":"ltr"},{"lang":"ann","autonym":"Obolo","dir":"ltr"},{"lang":"anp","autonym":"अंगिका","dir":"ltr"},{"lang":"ary","autonym":"الدارجة","dir":"rtl"},{"lang":"arz","autonym":"مصرى","dir":"rtl"},{"lang":"as","autonym":"অসমীয়া","dir":"ltr"},{"lang":"ast","autonym":"asturianu","dir":"ltr"},{"lang":"av","autonym":"авар","dir":"ltr" },{"lang":"avk","autonym":"Kotava","dir":"ltr"},{"lang":"awa","autonym":"अवधी","dir":"ltr"},{"lang":"ay","autonym":"Aymar aru","dir":"ltr"},{"lang":"az","autonym":"azərbaycanca","dir":"ltr"},{"lang":"azb","autonym":"تۆرکجه","dir":"rtl"},{"lang":"ba","autonym":"башҡортса","dir":"ltr"},{"lang":"ban","autonym":"Basa Bali","dir":"ltr"},{"lang":"bar","autonym":"Boarisch","dir":"ltr"},{"lang":"bbc","autonym":"Batak Toba","dir":"ltr"},{"lang":"bcl","autonym":"Bikol Central","dir":"ltr"},{"lang":"bdr","autonym":"Bajau Sama","dir":"ltr"},{"lang":"be","autonym":"беларуская","dir":"ltr"},{"lang":"bew","autonym":"Betawi","dir":"ltr"},{"lang":"bg","autonym":"български","dir":"ltr"},{"lang":"bho","autonym":"भोजपुरी","dir":"ltr"},{"lang":"bi","autonym":"Bislama","dir":"ltr"},{"lang":"bjn","autonym":"Banjar","dir":"ltr"},{"lang":"blk","autonym":"ပအိုဝ်ႏဘာႏသာႏ","dir":"ltr"},{"lang":"bm","autonym":"bamanankan","dir":"ltr" },{"lang":"bn","autonym":"বাংলা","dir":"ltr"},{"lang":"bo","autonym":"བོད་ཡིག","dir":"ltr"},{"lang":"bpy","autonym":"বিষ্ণুপ্রিয়া মণিপুরী","dir":"ltr"},{"lang":"br","autonym":"brezhoneg","dir":"ltr"},{"lang":"bs","autonym":"bosanski","dir":"ltr"},{"lang":"btm","autonym":"Batak Mandailing","dir":"ltr"},{"lang":"bug","autonym":"Basa Ugi","dir":"ltr"},{"lang":"ca","autonym":"català","dir":"ltr"},{"lang":"cdo","autonym":"閩東語 / Mìng-dĕ̤ng-ngṳ̄","dir":"ltr"},{"lang":"ce","autonym":"нохчийн","dir":"ltr"},{"lang":"ceb","autonym":"Cebuano","dir":"ltr"},{"lang":"ch","autonym":"Chamoru","dir":"ltr"},{"lang":"chr","autonym":"ᏣᎳᎩ","dir":"ltr"},{"lang":"ckb","autonym":"کوردی","dir":"rtl"},{"lang":"co","autonym":"corsu","dir":"ltr"},{"lang":"cr","autonym":"Nēhiyawēwin / ᓀᐦᐃᔭᐍᐏᐣ","dir":"ltr"},{"lang":"crh","autonym":"qırımtatarca","dir":"ltr"},{"lang":"cs","autonym":"čeština","dir":"ltr" },{"lang":"cu","autonym":"словѣньскъ / ⰔⰎⰑⰂⰡⰐⰠⰔⰍⰟ","dir":"ltr"},{"lang":"cy","autonym":"Cymraeg","dir":"ltr"},{"lang":"da","autonym":"dansk","dir":"ltr"},{"lang":"dag","autonym":"dagbanli","dir":"ltr"},{"lang":"dga","autonym":"Dagaare","dir":"ltr"},{"lang":"din","autonym":"Thuɔŋjäŋ","dir":"ltr"},{"lang":"diq","autonym":"Zazaki","dir":"ltr"},{"lang":"dsb","autonym":"dolnoserbski","dir":"ltr"},{"lang":"dtp","autonym":"Kadazandusun","dir":"ltr"},{"lang":"dv","autonym":"ދިވެހިބަސް","dir":"rtl"},{"lang":"dz","autonym":"ཇོང་ཁ","dir":"ltr"},{"lang":"ee","autonym":"eʋegbe","dir":"ltr"},{"lang":"el","autonym":"Ελληνικά","dir":"ltr"},{"lang":"eml","autonym":"emiliàn e rumagnòl","dir":"ltr"},{"lang":"eo","autonym":"Esperanto","dir":"ltr"},{"lang":"es","autonym":"español","dir":"ltr"},{"lang":"et","autonym":"eesti","dir":"ltr"},{"lang":"eu","autonym":"euskara","dir":"ltr"},{"lang":"fa","autonym":"فارسی","dir":"rtl"},{"lang": "fat","autonym":"mfantse","dir":"ltr"},{"lang":"ff","autonym":"Fulfulde","dir":"ltr"},{"lang":"fi","autonym":"suomi","dir":"ltr"},{"lang":"fj","autonym":"Na Vosa Vakaviti","dir":"ltr"},{"lang":"fo","autonym":"føroyskt","dir":"ltr"},{"lang":"fon","autonym":"fɔ̀ngbè","dir":"ltr"},{"lang":"frp","autonym":"arpetan","dir":"ltr"},{"lang":"frr","autonym":"Nordfriisk","dir":"ltr"},{"lang":"fur","autonym":"furlan","dir":"ltr"},{"lang":"fy","autonym":"Frysk","dir":"ltr"},{"lang":"gag","autonym":"Gagauz","dir":"ltr"},{"lang":"gan","autonym":"贛語","dir":"ltr"},{"lang":"gcr","autonym":"kriyòl gwiyannen","dir":"ltr"},{"lang":"gl","autonym":"galego","dir":"ltr"},{"lang":"glk","autonym":"گیلکی","dir":"rtl"},{"lang":"gn","autonym":"Avañe'ẽ","dir":"ltr"},{"lang":"gom","autonym":"गोंयची कोंकणी / Gõychi Konknni","dir":"ltr"},{"lang":"gor","autonym":"Bahasa Hulontalo","dir":"ltr"},{"lang":"gpe","autonym":"Ghanaian Pidgin","dir":"ltr"},{"lang":"gu","autonym": "ગુજરાતી","dir":"ltr"},{"lang":"guc","autonym":"wayuunaiki","dir":"ltr"},{"lang":"gur","autonym":"farefare","dir":"ltr"},{"lang":"guw","autonym":"gungbe","dir":"ltr"},{"lang":"gv","autonym":"Gaelg","dir":"ltr"},{"lang":"ha","autonym":"Hausa","dir":"ltr"},{"lang":"hak","autonym":"客家語 / Hak-kâ-ngî","dir":"ltr"},{"lang":"haw","autonym":"Hawaiʻi","dir":"ltr"},{"lang":"he","autonym":"עברית","dir":"rtl"},{"lang":"hi","autonym":"हिन्दी","dir":"ltr"},{"lang":"hif","autonym":"Fiji Hindi","dir":"ltr"},{"lang":"hr","autonym":"hrvatski","dir":"ltr"},{"lang":"hsb","autonym":"hornjoserbsce","dir":"ltr"},{"lang":"ht","autonym":"Kreyòl ayisyen","dir":"ltr"},{"lang":"hu","autonym":"magyar","dir":"ltr"},{"lang":"hy","autonym":"հայերեն","dir":"ltr"},{"lang":"hyw","autonym":"Արեւմտահայերէն","dir":"ltr"},{"lang":"ia","autonym":"interlingua","dir":"ltr"},{"lang":"iba","autonym":"Jaku Iban","dir":"ltr"},{"lang":"ie","autonym":"Interlingue","dir": "ltr"},{"lang":"ig","autonym":"Igbo","dir":"ltr"},{"lang":"igl","autonym":"Igala","dir":"ltr"},{"lang":"ilo","autonym":"Ilokano","dir":"ltr"},{"lang":"io","autonym":"Ido","dir":"ltr"},{"lang":"is","autonym":"íslenska","dir":"ltr"},{"lang":"it","autonym":"italiano","dir":"ltr"},{"lang":"iu","autonym":"ᐃᓄᒃᑎᑐᑦ / inuktitut","dir":"ltr"},{"lang":"ja","autonym":"日本語","dir":"ltr"},{"lang":"jam","autonym":"Patois","dir":"ltr"},{"lang":"jv","autonym":"Jawa","dir":"ltr"},{"lang":"ka","autonym":"ქართული","dir":"ltr"},{"lang":"kaa","autonym":"Qaraqalpaqsha","dir":"ltr"},{"lang":"kab","autonym":"Taqbaylit","dir":"ltr"},{"lang":"kbd","autonym":"адыгэбзэ","dir":"ltr"},{"lang":"kbp","autonym":"Kabɩyɛ","dir":"ltr"},{"lang":"kcg","autonym":"Tyap","dir":"ltr"},{"lang":"kg","autonym":"Kongo","dir":"ltr"},{"lang":"kge","autonym":"Kumoring","dir":"ltr"},{"lang":"ki","autonym":"Gĩkũyũ","dir":"ltr"},{"lang":"kk","autonym":"қазақша","dir":"ltr"},{"lang":"kl" ,"autonym":"kalaallisut","dir":"ltr"},{"lang":"km","autonym":"ភាសាខ្មែរ","dir":"ltr"},{"lang":"kn","autonym":"ಕನ್ನಡ","dir":"ltr"},{"lang":"ko","autonym":"한국어","dir":"ltr"},{"lang":"koi","autonym":"перем коми","dir":"ltr"},{"lang":"krc","autonym":"къарачай-малкъар","dir":"ltr"},{"lang":"ks","autonym":"कॉशुर / کٲشُر","dir":"rtl"},{"lang":"ku","autonym":"kurdî","dir":"ltr"},{"lang":"kus","autonym":"Kʋsaal","dir":"ltr"},{"lang":"kv","autonym":"коми","dir":"ltr"},{"lang":"kw","autonym":"kernowek","dir":"ltr"},{"lang":"ky","autonym":"кыргызча","dir":"ltr"},{"lang":"lad","autonym":"Ladino","dir":"ltr"},{"lang":"lb","autonym":"Lëtzebuergesch","dir":"ltr"},{"lang":"lez","autonym":"лезги","dir":"ltr"},{"lang":"lg","autonym":"Luganda","dir":"ltr"},{"lang":"li","autonym":"Limburgs","dir":"ltr"},{"lang":"lij","autonym":"Ligure","dir":"ltr"},{"lang":"lld","autonym":"Ladin","dir":"ltr"},{"lang":"lmo", "autonym":"lombard","dir":"ltr"},{"lang":"ln","autonym":"lingála","dir":"ltr"},{"lang":"lo","autonym":"ລາວ","dir":"ltr"},{"lang":"lt","autonym":"lietuvių","dir":"ltr"},{"lang":"ltg","autonym":"latgaļu","dir":"ltr"},{"lang":"lv","autonym":"latviešu","dir":"ltr"},{"lang":"mad","autonym":"Madhurâ","dir":"ltr"},{"lang":"mai","autonym":"मैथिली","dir":"ltr"},{"lang":"map-bms","autonym":"Basa Banyumasan","dir":"ltr"},{"lang":"mdf","autonym":"мокшень","dir":"ltr"},{"lang":"mg","autonym":"Malagasy","dir":"ltr"},{"lang":"mhr","autonym":"олык марий","dir":"ltr"},{"lang":"mi","autonym":"Māori","dir":"ltr"},{"lang":"min","autonym":"Minangkabau","dir":"ltr"},{"lang":"mk","autonym":"македонски","dir":"ltr"},{"lang":"ml","autonym":"മലയാളം","dir":"ltr"},{"lang":"mn","autonym":"монгол","dir":"ltr"},{"lang":"mni","autonym":"ꯃꯤꯇꯩ ꯂꯣꯟ","dir":"ltr"},{"lang":"mnw","autonym":"ဘာသာမန်","dir":"ltr"},{"lang":"mos", "autonym":"moore","dir":"ltr"},{"lang":"mr","autonym":"मराठी","dir":"ltr"},{"lang":"mrj","autonym":"кырык мары","dir":"ltr"},{"lang":"ms","autonym":"Bahasa Melayu","dir":"ltr"},{"lang":"mt","autonym":"Malti","dir":"ltr"},{"lang":"mwl","autonym":"Mirandés","dir":"ltr"},{"lang":"my","autonym":"မြန်မာဘာသာ","dir":"ltr"},{"lang":"myv","autonym":"эрзянь","dir":"ltr"},{"lang":"mzn","autonym":"مازِرونی","dir":"rtl"},{"lang":"nah","autonym":"Nāhuatl","dir":"ltr"},{"lang":"nan","autonym":"閩南語 / Bân-lâm-gú","dir":"ltr"},{"lang":"nap","autonym":"Napulitano","dir":"ltr"},{"lang":"nb","autonym":"norsk bokmål","dir":"ltr"},{"lang":"nds","autonym":"Plattdüütsch","dir":"ltr"},{"lang":"nds-nl","autonym":"Nedersaksies","dir":"ltr"},{"lang":"ne","autonym":"नेपाली","dir":"ltr"},{"lang":"new","autonym":"नेपाल भाषा","dir":"ltr"},{"lang":"nia","autonym":"Li Niha","dir":"ltr"},{"lang":"nl","autonym":"Nederlands", "dir":"ltr"},{"lang":"nn","autonym":"norsk nynorsk","dir":"ltr"},{"lang":"nqo","autonym":"ߒߞߏ","dir":"rtl"},{"lang":"nr","autonym":"isiNdebele seSewula","dir":"ltr"},{"lang":"nso","autonym":"Sesotho sa Leboa","dir":"ltr"},{"lang":"ny","autonym":"Chi-Chewa","dir":"ltr"},{"lang":"oc","autonym":"occitan","dir":"ltr"},{"lang":"om","autonym":"Oromoo","dir":"ltr"},{"lang":"or","autonym":"ଓଡ଼ିଆ","dir":"ltr"},{"lang":"os","autonym":"ирон","dir":"ltr"},{"lang":"pa","autonym":"ਪੰਜਾਬੀ","dir":"ltr"},{"lang":"pag","autonym":"Pangasinan","dir":"ltr"},{"lang":"pam","autonym":"Kapampangan","dir":"ltr"},{"lang":"pap","autonym":"Papiamentu","dir":"ltr"},{"lang":"pcd","autonym":"Picard","dir":"ltr"},{"lang":"pcm","autonym":"Naijá","dir":"ltr"},{"lang":"pdc","autonym":"Deitsch","dir":"ltr"},{"lang":"pl","autonym":"polski","dir":"ltr"},{"lang":"pms","autonym":"Piemontèis","dir":"ltr"},{"lang":"pnb","autonym":"پنجابی","dir":"rtl"},{"lang":"ps","autonym":"پښتو","dir": "rtl"},{"lang":"pt","autonym":"português","dir":"ltr"},{"lang":"pwn","autonym":"pinayuanan","dir":"ltr"},{"lang":"qu","autonym":"Runa Simi","dir":"ltr"},{"lang":"rm","autonym":"rumantsch","dir":"ltr"},{"lang":"rn","autonym":"ikirundi","dir":"ltr"},{"lang":"ro","autonym":"română","dir":"ltr"},{"lang":"rsk","autonym":"руски","dir":"ltr"},{"lang":"rue","autonym":"русиньскый","dir":"ltr"},{"lang":"rup","autonym":"armãneashti","dir":"ltr"},{"lang":"rw","autonym":"Ikinyarwanda","dir":"ltr"},{"lang":"sa","autonym":"संस्कृतम्","dir":"ltr"},{"lang":"sah","autonym":"саха тыла","dir":"ltr"},{"lang":"sat","autonym":"ᱥᱟᱱᱛᱟᱲᱤ","dir":"ltr"},{"lang":"sc","autonym":"sardu","dir":"ltr"},{"lang":"scn","autonym":"sicilianu","dir":"ltr"},{"lang":"sco","autonym":"Scots","dir":"ltr"},{"lang":"sd","autonym":"سنڌي","dir":"rtl"},{"lang":"se","autonym":"davvisámegiella","dir":"ltr"},{"lang":"sg","autonym":"Sängö","dir":"ltr"},{"lang":"sgs", "autonym":"žemaitėška","dir":"ltr"},{"lang":"sh","autonym":"srpskohrvatski / српскохрватски","dir":"ltr"},{"lang":"shi","autonym":"Taclḥit","dir":"ltr"},{"lang":"shn","autonym":"ၽႃႇသႃႇတႆး ","dir":"ltr"},{"lang":"si","autonym":"සිංහල","dir":"ltr"},{"lang":"sk","autonym":"slovenčina","dir":"ltr"},{"lang":"skr","autonym":"سرائیکی","dir":"rtl"},{"lang":"sl","autonym":"slovenščina","dir":"ltr"},{"lang":"sm","autonym":"Gagana Samoa","dir":"ltr"},{"lang":"smn","autonym":"anarâškielâ","dir":"ltr"},{"lang":"sn","autonym":"chiShona","dir":"ltr"},{"lang":"so","autonym":"Soomaaliga","dir":"ltr"},{"lang":"sq","autonym":"shqip","dir":"ltr"},{"lang":"sr","autonym":"српски / srpski","dir":"ltr"},{"lang":"srn","autonym":"Sranantongo","dir":"ltr"},{"lang":"ss","autonym":"SiSwati","dir":"ltr"},{"lang":"st","autonym":"Sesotho","dir":"ltr"},{"lang":"stq","autonym":"Seeltersk","dir":"ltr"},{"lang":"su","autonym":"Sunda","dir":"ltr"},{"lang": "sv","autonym":"svenska","dir":"ltr"},{"lang":"sw","autonym":"Kiswahili","dir":"ltr"},{"lang":"szl","autonym":"ślůnski","dir":"ltr"},{"lang":"ta","autonym":"தமிழ்","dir":"ltr"},{"lang":"tay","autonym":"Tayal","dir":"ltr"},{"lang":"tcy","autonym":"ತುಳು","dir":"ltr"},{"lang":"tdd","autonym":"ᥖᥭᥰ ᥖᥬᥲ ᥑᥨᥒᥰ","dir":"ltr"},{"lang":"te","autonym":"తెలుగు","dir":"ltr"},{"lang":"tet","autonym":"tetun","dir":"ltr"},{"lang":"tg","autonym":"тоҷикӣ","dir":"ltr"},{"lang":"th","autonym":"ไทย","dir":"ltr"},{"lang":"ti","autonym":"ትግርኛ","dir":"ltr"},{"lang":"tk","autonym":"Türkmençe","dir":"ltr"},{"lang":"tl","autonym":"Tagalog","dir":"ltr"},{"lang":"tly","autonym":"tolışi","dir":"ltr"},{"lang":"tn","autonym":"Setswana","dir":"ltr"},{"lang":"to","autonym":"lea faka-Tonga","dir":"ltr"},{"lang":"tpi","autonym":"Tok Pisin","dir":"ltr"},{"lang":"tr","autonym":"Türkçe","dir":"ltr"},{"lang":"trv","autonym":"Seediq","dir":"ltr"},{ "lang":"ts","autonym":"Xitsonga","dir":"ltr"},{"lang":"tt","autonym":"татарча / tatarça","dir":"ltr"},{"lang":"tum","autonym":"chiTumbuka","dir":"ltr"},{"lang":"tw","autonym":"Twi","dir":"ltr"},{"lang":"ty","autonym":"reo tahiti","dir":"ltr"},{"lang":"tyv","autonym":"тыва дыл","dir":"ltr"},{"lang":"udm","autonym":"удмурт","dir":"ltr"},{"lang":"ur","autonym":"اردو","dir":"rtl"},{"lang":"uz","autonym":"oʻzbekcha / ўзбекча","dir":"ltr"},{"lang":"ve","autonym":"Tshivenda","dir":"ltr"},{"lang":"vec","autonym":"vèneto","dir":"ltr"},{"lang":"vep","autonym":"vepsän kel’","dir":"ltr"},{"lang":"vi","autonym":"Tiếng Việt","dir":"ltr"},{"lang":"vls","autonym":"West-Vlams","dir":"ltr"},{"lang":"vo","autonym":"Volapük","dir":"ltr"},{"lang":"vro","autonym":"võro","dir":"ltr"},{"lang":"wa","autonym":"walon","dir":"ltr"},{"lang":"war","autonym":"Winaray","dir":"ltr"},{"lang":"wo","autonym":"Wolof","dir":"ltr"},{"lang":"wuu","autonym":"吴语","dir":"ltr"},{ "lang":"xal","autonym":"хальмг","dir":"ltr"},{"lang":"xh","autonym":"isiXhosa","dir":"ltr"},{"lang":"xmf","autonym":"მარგალური","dir":"ltr"},{"lang":"yi","autonym":"ייִדיש","dir":"rtl"},{"lang":"yo","autonym":"Yorùbá","dir":"ltr"},{"lang":"yue","autonym":"粵語","dir":"ltr"},{"lang":"za","autonym":"Vahcuengh","dir":"ltr"},{"lang":"zgh","autonym":"ⵜⴰⵎⴰⵣⵉⵖⵜ ⵜⴰⵏⴰⵡⴰⵢⵜ","dir":"ltr"},{"lang":"zh","autonym":"中文","dir":"ltr"},{"lang":"zu","autonym":"isiZulu","dir":"ltr"}],"wgSectionTranslationTargetLanguages":["ace","ady","alt","am","ami","an","ang","ann","anp","ar","ary","arz","as","ast","av","avk","awa","ay","az","azb","ba","ban","bar","bbc","bcl","bdr","be","bew","bg","bho","bi","bjn","blk","bm","bn","bo","bpy","br","bs","btm","bug","ca","cdo","ce","ceb","ch","chr","ckb","co","cr","crh","cs","cu","cy","da","dag","de","dga","din","diq","dsb","dtp","dv","dz","ee","el","eml","eo","es","et","eu","fa","fat","ff","fi","fj","fo", "fon","fr","frp","frr","fur","fy","gag","gan","gcr","gl","glk","gn","gom","gor","gpe","gu","guc","gur","guw","gv","ha","hak","haw","he","hi","hif","hr","hsb","ht","hu","hy","hyw","ia","iba","ie","ig","igl","ilo","io","is","it","iu","ja","jam","jv","ka","kaa","kab","kbd","kbp","kcg","kg","kge","ki","kk","kl","km","kn","ko","koi","krc","ks","ku","kus","kv","kw","ky","lad","lb","lez","lg","li","lij","lld","lmo","ln","lo","lt","ltg","lv","mad","mai","map-bms","mdf","mg","mhr","mi","min","mk","ml","mn","mni","mnw","mos","mr","mrj","ms","mt","mwl","my","myv","mzn","nah","nan","nap","nb","nds","nds-nl","ne","new","nia","nl","nn","nqo","nr","nso","ny","oc","om","or","os","pa","pag","pam","pap","pcd","pcm","pdc","pl","pms","pnb","ps","pt","pwn","qu","rm","rn","ro","rsk","rue","rup","rw","sa","sah","sat","sc","scn","sco","sd","se","sg","sgs","sh","shi","shn","si","sk","skr","sl","sm","smn","sn","so","sq","sr","srn","ss","st","stq","su","sv","sw","szl","ta","tay","tcy","tdd","te","tet","tg","th", "ti","tk","tl","tly","tn","to","tpi","tr","trv","ts","tt","tum","tw","ty","tyv","udm","ur","uz","ve","vec","vep","vi","vls","vo","vro","wa","war","wo","wuu","xal","xh","xmf","yi","yo","yue","za","zgh","zh","zu"],"isLanguageSearcherCXEntrypointEnabled":true,"mintEntrypointLanguages":["ace","ast","azb","bcl","bjn","bh","crh","ff","fon","ig","is","ki","ks","lmo","min","sat","ss","tn","vec"],"wgWikibaseItemId":"Q3338664","wgCheckUserClientHintsHeadersJsApi":["brands","architecture","bitness","fullVersionList","mobile","model","platform","platformVersion"],"GEHomepageSuggestedEditsEnableTopics":true,"wgGETopicsMatchModeEnabled":false,"wgGEStructuredTaskRejectionReasonTextInputEnabled":false,"wgGELevelingUpEnabledForUser":false,"wgMinervaPermissions":{"watchable":true,"watch":false},"wgMinervaFeatures":{"beta":false,"donate":true,"mobileOptionsLink":true,"categories":false,"pageIssues":true,"talkAtTop":true,"historyInPageActions":false,"overflowSubmenu":false,"tabsOnSpecials":true, "personalMenu":false,"mainMenuExpanded":false,"echo":true,"nightMode":true},"wgMinervaDownloadNamespaces":[0]};RLSTATE={"ext.globalCssJs.user.styles":"ready","site.styles":"ready","user.styles":"ready","ext.globalCssJs.user":"ready","user":"ready","user.options":"loading","ext.cite.styles":"ready","skins.minerva.styles":"ready","skins.minerva.content.styles.images":"ready","mediawiki.hlist":"ready","skins.minerva.codex.styles":"ready","skins.minerva.icons":"ready","skins.minerva.amc.styles":"ready","ext.wikimediamessages.styles":"ready","mobile.init.styles":"ready","ext.relatedArticles.styles":"ready","wikibase.client.init":"ready","ext.wikimediaBadges":"ready"};RLPAGEMODULES=["mediawiki.action.view.redirect","ext.cite.ux-enhancements","mediawiki.page.media","site","mediawiki.page.ready","skins.minerva.scripts","ext.centralNotice.geoIP","ext.centralNotice.startUp","ext.gadget.switcher","ext.urlShortener.toolbar","ext.centralauth.centralautologin","ext.popups","mobile.init", "ext.echo.centralauth","ext.relatedArticles.readMore.bootstrap","ext.eventLogging","ext.wikimediaEvents","ext.navigationTiming","ext.cx.eventlogging.campaigns","ext.cx.entrypoints.mffrequentlanguages","ext.cx.entrypoints.languagesearcher.init","mw.externalguidance.init","ext.checkUser.clientHints","ext.quicksurveys.init","ext.growthExperiments.SuggestedEditSession","wikibase.sidebar.tracking"];</script> <script>(RLQ=window.RLQ||[]).push(function(){mw.loader.impl(function(){return["user.options@12s5i",function($,jQuery,require,module){mw.user.tokens.set({"patrolToken":"+\\","watchToken":"+\\","csrfToken":"+\\"}); }];});});</script> <link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.cite.styles%7Cext.relatedArticles.styles%7Cext.wikimediaBadges%7Cext.wikimediamessages.styles%7Cmediawiki.hlist%7Cmobile.init.styles%7Cskins.minerva.amc.styles%7Cskins.minerva.codex.styles%7Cskins.minerva.content.styles.images%7Cskins.minerva.icons%2Cstyles%7Cwikibase.client.init&amp;only=styles&amp;skin=minerva"> <script async="" src="/w/load.php?lang=en&amp;modules=startup&amp;only=scripts&amp;raw=1&amp;skin=minerva"></script> <meta name="ResourceLoaderDynamicStyles" content=""> <link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=site.styles&amp;only=styles&amp;skin=minerva"> <meta name="generator" content="MediaWiki 1.44.0-wmf.5"> <meta name="referrer" content="origin"> <meta name="referrer" content="origin-when-cross-origin"> <meta name="robots" content="max-image-preview:standard"> <meta name="format-detection" content="telephone=no"> <meta name="theme-color" content="#eaecf0"> <meta property="og:image" content="https://upload.wikimedia.org/wikipedia/commons/2/26/Gray745.png"> <meta property="og:image:width" content="1200"> <meta property="og:image:height" content="975"> <meta property="og:image" content="https://upload.wikimedia.org/wikipedia/commons/2/26/Gray745.png"> <meta property="og:image:width" content="800"> <meta property="og:image:height" content="650"> <meta property="og:image:width" content="640"> <meta property="og:image:height" content="520"> <meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes, minimum-scale=0.25, maximum-scale=5.0"> <meta property="og:title" content="Neuroferritinopathy - Wikipedia"> <meta property="og:type" content="website"> <link rel="preconnect" href="//upload.wikimedia.org"> <link rel="manifest" href="/w/api.php?action=webapp-manifest"> <link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Neuroferritinopathy&amp;action=edit"> <link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png"> <link rel="icon" href="/static/favicon/wikipedia.ico"> <link rel="search" type="application/opensearchdescription+xml" href="/w/rest.php/v1/search" title="Wikipedia (en)"> <link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd"> <link rel="canonical" href="https://en.wikipedia.org/wiki/Neuroferritinopathy"> <link rel="license" href="https://creativecommons.org/licenses/by-sa/4.0/deed.en"> <link rel="dns-prefetch" href="//meta.wikimedia.org" /> <link rel="dns-prefetch" href="//login.wikimedia.org"> </head> <body class="mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject mw-editable page-Neuroferritinopathy rootpage-Neuroferritinopathy stable issues-group-B skin-minerva action-view skin--responsive mw-mf-amc-disabled mw-mf"><div id="mw-mf-viewport"> <div id="mw-mf-page-center"> <a class="mw-mf-page-center__mask" href="#"></a> <header class="header-container header-chrome"> <div class="minerva-header"> <nav class="navigation-drawer toggle-list view-border-box"> <input type="checkbox" id="main-menu-input" class="toggle-list__checkbox" role="button" aria-haspopup="true" aria-expanded="false" aria-labelledby="mw-mf-main-menu-button"> <label role="button" for="main-menu-input" id="mw-mf-main-menu-button" aria-hidden="true" data-event-name="ui.mainmenu" class="cdx-button cdx-button--size-large cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--icon-only cdx-button--weight-quiet toggle-list__toggle"> <span class="minerva-icon minerva-icon--menu"></span> <span></span> </label> <div id="mw-mf-page-left" class="menu view-border-box"> <ul id="p-navigation" class="toggle-list__list"> <li class="toggle-list-item "> <a class="toggle-list-item__anchor menu__item--home" href="/wiki/Main_Page" data-mw="interface"> <span class="minerva-icon minerva-icon--home"></span> <span class="toggle-list-item__label">Home</span> </a> </li> <li class="toggle-list-item "> <a class="toggle-list-item__anchor menu__item--random" href="/wiki/Special:Random" data-mw="interface"> <span class="minerva-icon minerva-icon--die"></span> <span class="toggle-list-item__label">Random</span> </a> </li> <li class="toggle-list-item skin-minerva-list-item-jsonly"> <a class="toggle-list-item__anchor menu__item--nearby" href="/wiki/Special:Nearby" data-event-name="menu.nearby" data-mw="interface"> <span class="minerva-icon minerva-icon--mapPin"></span> <span class="toggle-list-item__label">Nearby</span> </a> </li> </ul> <ul id="p-personal" class="toggle-list__list"> <li class="toggle-list-item "> <a class="toggle-list-item__anchor menu__item--login" href="/w/index.php?title=Special:UserLogin&amp;returnto=Neuroferritinopathy" data-event-name="menu.login" data-mw="interface"> <span class="minerva-icon minerva-icon--logIn"></span> <span class="toggle-list-item__label">Log in</span> </a> </li> </ul> <ul id="pt-preferences" class="toggle-list__list"> <li class="toggle-list-item skin-minerva-list-item-jsonly"> <a class="toggle-list-item__anchor menu__item--settings" href="/w/index.php?title=Special:MobileOptions&amp;returnto=Neuroferritinopathy" data-event-name="menu.settings" data-mw="interface"> <span class="minerva-icon minerva-icon--settings"></span> <span class="toggle-list-item__label">Settings</span> </a> </li> </ul> <ul id="p-donation" class="toggle-list__list"> <li class="toggle-list-item "> <a class="toggle-list-item__anchor menu__item--donate" href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en&amp;wmf_key=minerva" data-event-name="menu.donate" data-mw="interface"> <span class="minerva-icon minerva-icon--heart"></span> <span class="toggle-list-item__label">Donate</span> </a> </li> </ul> <ul class="hlist"> <li class="toggle-list-item "> <a class="toggle-list-item__anchor menu__item--about" href="/wiki/Wikipedia:About" data-mw="interface"> <span class="toggle-list-item__label">About Wikipedia</span> </a> </li> <li class="toggle-list-item "> <a class="toggle-list-item__anchor menu__item--disclaimers" href="/wiki/Wikipedia:General_disclaimer" data-mw="interface"> <span class="toggle-list-item__label">Disclaimers</span> </a> </li> </ul> </div> <label class="main-menu-mask" for="main-menu-input"></label> </nav> <div class="branding-box"> <a href="/wiki/Main_Page"> <span><img src="/static/images/mobile/copyright/wikipedia-wordmark-en.svg" alt="Wikipedia" width="120" height="18" style="width: 7.5em; height: 1.125em;"/> </span> </a> </div> <form action="/w/index.php" method="get" class="minerva-search-form"> <div class="search-box"> <input type="hidden" name="title" value="Special:Search"/> <input class="search skin-minerva-search-trigger" id="searchInput" type="search" name="search" placeholder="Search Wikipedia" aria-label="Search Wikipedia" autocapitalize="sentences" title="Search Wikipedia [f]" accesskey="f"> <span class="search-box-icon-overlay"><span class="minerva-icon minerva-icon--search"></span> </span> </div> <button id="searchIcon" class="cdx-button cdx-button--size-large cdx-button--icon-only cdx-button--weight-quiet skin-minerva-search-trigger"> <span class="minerva-icon minerva-icon--search"></span> <span>Search</span> </button> </form> <nav class="minerva-user-navigation" aria-label="User navigation"> </nav> </div> </header> <main id="content" class="mw-body"> <div class="banner-container"> <div id="siteNotice"></div> </div> <div class="pre-content heading-holder"> <div class="page-heading"> <h1 id="firstHeading" class="firstHeading mw-first-heading"><span class="mw-page-title-main">Neuroferritinopathy</span></h1> <div class="tagline"></div> </div> <ul id="p-associated-pages" class="minerva__tab-container"> <li class="minerva__tab selected"> <a class="minerva__tab-text" href="/wiki/Neuroferritinopathy" rel="" data-event-name="tabs.subject">Article</a> </li> <li class="minerva__tab "> <a class="minerva__tab-text" href="/wiki/Talk:Neuroferritinopathy" rel="discussion" data-event-name="tabs.talk">Talk</a> </li> </ul> <nav class="page-actions-menu"> <ul id="p-views" class="page-actions-menu__list"> <li id="language-selector" class="page-actions-menu__list-item"> <a role="button" href="#p-lang" data-mw="interface" data-event-name="menu.languages" title="Language" class="cdx-button cdx-button--size-large cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--icon-only cdx-button--weight-quiet language-selector"> <span class="minerva-icon minerva-icon--language"></span> <span>Language</span> </a> </li> <li id="page-actions-watch" class="page-actions-menu__list-item"> <a role="button" id="ca-watch" href="/w/index.php?title=Special:UserLogin&amp;returnto=Neuroferritinopathy" data-event-name="menu.watch" class="cdx-button cdx-button--size-large cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--icon-only cdx-button--weight-quiet menu__item--page-actions-watch"> <span class="minerva-icon minerva-icon--star"></span> <span>Watch</span> </a> </li> <li id="page-actions-edit" class="page-actions-menu__list-item"> <a role="button" id="ca-edit" href="/w/index.php?title=Neuroferritinopathy&amp;action=edit" data-event-name="menu.edit" data-mw="interface" class="cdx-button cdx-button--size-large cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--icon-only cdx-button--weight-quiet edit-page menu__item--page-actions-edit"> <span class="minerva-icon minerva-icon--edit"></span> <span>Edit</span> </a> </li> </ul> </nav> <!-- version 1.0.2 (change every time you update a partial) --> <div id="mw-content-subtitle"><span class="mw-redirectedfrom">(Redirected from <a href="/w/index.php?title=Adult-onset_basal_ganglia_disease&amp;redirect=no" class="mw-redirect" title="Adult-onset basal ganglia disease">Adult-onset basal ganglia disease</a>)</span></div> </div> <div id="bodyContent" class="content"> <div id="mw-content-text" class="mw-body-content"><script>function mfTempOpenSection(id){var block=document.getElementById("mf-section-"+id);block.className+=" open-block";block.previousSibling.className+=" open-block";}</script><div class="mw-content-ltr mw-parser-output" lang="en" dir="ltr"><section class="mf-section-0" id="mf-section-0"><style data-mw-deduplicate="TemplateStyles:r1257001546">.mw-parser-output .infobox-subbox{padding:0;border:none;margin:-3px;width:auto;min-width:100%;font-size:100%;clear:none;float:none;background-color:transparent}.mw-parser-output .infobox-3cols-child{margin:auto}.mw-parser-output .infobox .navbar{font-size:100%}@media screen{html.skin-theme-clientpref-night .mw-parser-output .infobox-full-data:not(.notheme)>div:not(.notheme)[style]{background:#1f1f23!important;color:#f8f9fa}}@media screen and (prefers-color-scheme:dark){html.skin-theme-clientpref-os .mw-parser-output .infobox-full-data:not(.notheme) div:not(.notheme){background:#1f1f23!important;color:#f8f9fa}}@media(min-width:640px){body.skin--responsive .mw-parser-output .infobox-table{display:table!important}body.skin--responsive .mw-parser-output .infobox-table>caption{display:table-caption!important}body.skin--responsive .mw-parser-output .infobox-table>tbody{display:table-row-group}body.skin--responsive .mw-parser-output .infobox-table tr{display:table-row!important}body.skin--responsive .mw-parser-output .infobox-table th,body.skin--responsive .mw-parser-output .infobox-table td{padding-left:inherit;padding-right:inherit}}</style><p><b>Neuroferritinopathy</b> is a genetic <a href="/wiki/Neurodegeneration" class="mw-redirect" title="Neurodegeneration">neurodegenerative disorder</a> characterized by the accumulation of <a href="/wiki/Iron" title="Iron">iron</a> in the <a href="/wiki/Basal_ganglia" title="Basal ganglia">basal ganglia</a>, <a href="/wiki/Cerebellum" title="Cerebellum">cerebellum</a>, and <a href="/wiki/Motor_cortex" title="Motor cortex">motor cortex</a> of the human brain. Symptoms, which are <a href="/wiki/Extrapyramidal_symptoms" title="Extrapyramidal symptoms">extrapyramidal</a> in nature, progress slowly and generally do not become apparent until adulthood.<sup id="cite_ref-Neuroferritinopathy-Current_understanding_review_1-0" class="reference"><a href="#cite_note-Neuroferritinopathy-Current_understanding_review-1"><span class="cite-bracket">[</span>1<span class="cite-bracket">]</span></a></sup> These symptoms include <a href="/wiki/Chorea" title="Chorea">chorea</a>, <a href="/wiki/Dystonia" title="Dystonia">dystonia</a>, and cognitive deficits which worsen with age.<sup id="cite_ref-Comprehensive_Medical_Overview_2-0" class="reference"><a href="#cite_note-Comprehensive_Medical_Overview-2"><span class="cite-bracket">[</span>2<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Zecca_3-0" class="reference"><a href="#cite_note-Zecca-3"><span class="cite-bracket">[</span>3<span class="cite-bracket">]</span></a></sup> </p><table class="infobox ib-medical-condition"><tbody><tr><th colspan="2" class="infobox-above" style="background:#ccc">Neuroferritinopathy</th></tr><tr><th scope="row" class="infobox-label">Other names</th><td class="infobox-data">Adult-onset basal ganglia disease</td></tr><tr style="background-color: #f8f9fa;"><td colspan="2" class="infobox-full-data"><span class="mw-default-size" typeof="mw:File/Frameless"><a href="/wiki/File:Gray745.png" class="mw-file-description"><img alt="Cerebellum and basal ganglia" src="//upload.wikimedia.org/wikipedia/commons/thumb/2/26/Gray745.png/220px-Gray745.png" decoding="async" width="220" height="179" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/2/26/Gray745.png/330px-Gray745.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/2/26/Gray745.png/440px-Gray745.png 2x" data-file-width="550" data-file-height="447"></a></span></td></tr><tr><td colspan="2" class="infobox-full-data">Cerebellum and basal ganglia</td></tr><tr><th scope="row" class="infobox-label"><a href="/wiki/Medical_specialty" title="Medical specialty">Specialty</a></th><td class="infobox-data"><a href="/wiki/Neurology" title="Neurology">Neurology</a> <span class="penicon autoconfirmed-show"><span class="mw-valign-text-top" typeof="mw:File/Frameless"><a href="https://www.wikidata.org/wiki/Q3338664?uselang=en#P1995" title="Edit this on Wikidata"><img alt="Edit this on Wikidata" src="//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/10px-OOjs_UI_icon_edit-ltr-progressive.svg.png" decoding="async" width="10" height="10" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/15px-OOjs_UI_icon_edit-ltr-progressive.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/20px-OOjs_UI_icon_edit-ltr-progressive.svg.png 2x" data-file-width="20" data-file-height="20"></a></span></span></td></tr></tbody></table> <p>This disorder is <a href="/wiki/Autosomal" class="mw-redirect" title="Autosomal">autosomal</a> <a href="/wiki/Dominance_(genetics)" title="Dominance (genetics)">dominant</a><sup id="cite_ref-Neuroferritinopathy-_Summary_of_published_data_4-0" class="reference"><a href="#cite_note-Neuroferritinopathy-_Summary_of_published_data-4"><span class="cite-bracket">[</span>4<span class="cite-bracket">]</span></a></sup> and is caused by mutations in the gene encoding the <a href="/wiki/Ferritin_light_chain" title="Ferritin light chain">light chain</a> subunit of the <a href="/wiki/Ferritin" title="Ferritin">ferritin</a> protein. Wild type ferritin functions as a buffer for iron, sequestering it and controlling its release. Thus, mutations in the light chain of ferritin result in the accumulation of iron in the brain which can be imaged using <a href="/wiki/MRI" class="mw-redirect" title="MRI">MRI</a>.<sup id="cite_ref-Comprehensive_Medical_Overview_2-1" class="reference"><a href="#cite_note-Comprehensive_Medical_Overview-2"><span class="cite-bracket">[</span>2<span class="cite-bracket">]</span></a></sup> Currently, neuroferritinopathy is the only neurodegenerative disease with an iron accumulation in the brain classified as an autosomal dominant syndrome.<sup id="cite_ref-Neuroferritinopathy-_Summary_of_published_data_4-1" class="reference"><a href="#cite_note-Neuroferritinopathy-_Summary_of_published_data-4"><span class="cite-bracket">[</span>4<span class="cite-bracket">]</span></a></sup> </p><p>Treatment of neuroferritinopathy is focused on managing symptoms associated with chorea and dystonia using standard medications for each.<sup id="cite_ref-Comprehensive_Medical_Overview_2-2" class="reference"><a href="#cite_note-Comprehensive_Medical_Overview-2"><span class="cite-bracket">[</span>2<span class="cite-bracket">]</span></a></sup> The disorder is progressive and symptoms become worse with age. Fewer than 100 cases of neuroferritinopathy have been reported since its identification in 2001.<sup id="cite_ref-Comprehensive_Medical_Overview_2-3" class="reference"><a href="#cite_note-Comprehensive_Medical_Overview-2"><span class="cite-bracket">[</span>2<span class="cite-bracket">]</span></a></sup> Its incidence has been largely localized to Northwest England, significantly in the Cumbria region<sup id="cite_ref-Neuroferritinopathy-_Summary_of_published_data_4-2" class="reference"><a href="#cite_note-Neuroferritinopathy-_Summary_of_published_data-4"><span class="cite-bracket">[</span>4<span class="cite-bracket">]</span></a></sup> suggesting a <a href="/wiki/Founder_effect" title="Founder effect">founder effect</a>.<sup id="cite_ref-Comprehensive_Medical_Overview_2-4" class="reference"><a href="#cite_note-Comprehensive_Medical_Overview-2"><span class="cite-bracket">[</span>2<span class="cite-bracket">]</span></a></sup> Due to its genetic nature, current research is focused on therapeutic management of the symptoms caused by the disorder.<sup id="cite_ref-Neuroferritinopathy-_Summary_of_published_data_4-3" class="reference"><a href="#cite_note-Neuroferritinopathy-_Summary_of_published_data-4"><span class="cite-bracket">[</span>4<span class="cite-bracket">]</span></a></sup> </p> <div id="toc" class="toc" role="navigation" aria-labelledby="mw-toc-heading"><input type="checkbox" role="button" id="toctogglecheckbox" class="toctogglecheckbox" style="display:none"><div class="toctitle" lang="en" dir="ltr"><h2 id="mw-toc-heading">Contents</h2><span class="toctogglespan"><label class="toctogglelabel" for="toctogglecheckbox"></label></span></div> <ul> <li class="toclevel-1 tocsection-1"><a href="#Signs_and_symptoms"><span class="tocnumber">1</span> <span class="toctext">Signs and symptoms</span></a> <ul> <li class="toclevel-2 tocsection-2"><a href="#Diagnostic_findings"><span class="tocnumber">1.1</span> <span class="toctext">Diagnostic findings</span></a></li> <li class="toclevel-2 tocsection-3"><a href="#Physical_symptoms"><span class="tocnumber">1.2</span> <span class="toctext">Physical symptoms</span></a></li> </ul> </li> <li class="toclevel-1 tocsection-4"><a href="#Causes"><span class="tocnumber">2</span> <span class="toctext">Causes</span></a></li> <li class="toclevel-1 tocsection-5"><a href="#Mechanism"><span class="tocnumber">3</span> <span class="toctext">Mechanism</span></a></li> <li class="toclevel-1 tocsection-6"><a href="#Diagnosis"><span class="tocnumber">4</span> <span class="toctext">Diagnosis</span></a> <ul> <li class="toclevel-2 tocsection-7"><a href="#Classification"><span class="tocnumber">4.1</span> <span class="toctext">Classification</span></a></li> <li class="toclevel-2 tocsection-8"><a href="#Neuroimaging"><span class="tocnumber">4.2</span> <span class="toctext">Neuroimaging</span></a></li> <li class="toclevel-2 tocsection-9"><a href="#Physiological_testing"><span class="tocnumber">4.3</span> <span class="toctext">Physiological testing</span></a></li> <li class="toclevel-2 tocsection-10"><a href="#Genetic_testing"><span class="tocnumber">4.4</span> <span class="toctext">Genetic testing</span></a></li> </ul> </li> <li class="toclevel-1 tocsection-11"><a href="#Treatment"><span class="tocnumber">5</span> <span class="toctext">Treatment</span></a></li> <li class="toclevel-1 tocsection-12"><a href="#Epidemiology"><span class="tocnumber">6</span> <span class="toctext">Epidemiology</span></a></li> <li class="toclevel-1 tocsection-13"><a href="#Research"><span class="tocnumber">7</span> <span class="toctext">Research</span></a></li> <li class="toclevel-1 tocsection-14"><a href="#References"><span class="tocnumber">8</span> <span class="toctext">References</span></a></li> <li class="toclevel-1 tocsection-15"><a href="#External_links"><span class="tocnumber">9</span> <span class="toctext">External links</span></a></li> </ul> </div> </section><div class="mw-heading mw-heading2 section-heading" onclick="mfTempOpenSection(1)"><span class="indicator mf-icon mf-icon-expand mf-icon--small"></span><h2 id="Signs_and_symptoms">Signs and symptoms</h2><span class="mw-editsection"> <a role="button" href="/w/index.php?title=Neuroferritinopathy&amp;action=edit&amp;section=1" title="Edit section: Signs and symptoms" class="cdx-button cdx-button--size-large cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--icon-only cdx-button--weight-quiet "> <span class="minerva-icon minerva-icon--edit"></span> <span>edit</span> </a> </span> </div><section class="mf-section-1 collapsible-block" id="mf-section-1"> <p>Neuroferritinopathy has several distinguishing signs and symptoms. These fall into two categories: diagnostic findings and physically visible symptoms. </p> <div class="mw-heading mw-heading3"><h3 id="Diagnostic_findings">Diagnostic findings</h3><span class="mw-editsection"> <a role="button" href="/w/index.php?title=Neuroferritinopathy&amp;action=edit&amp;section=2" title="Edit section: Diagnostic findings" class="cdx-button cdx-button--size-large cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--icon-only cdx-button--weight-quiet "> <span class="minerva-icon minerva-icon--edit"></span> <span>edit</span> </a> </span> </div> <p>Symptoms categorized as medically tested and diagnosed include iron accumulation in the brain, basal ganglia <a href="/wiki/Cavitation" title="Cavitation">cavitation</a>, and <a href="/wiki/Neurodegeneration" class="mw-redirect" title="Neurodegeneration">neurodegeneration</a>.<sup id="cite_ref-Neuroferritinopathy-_Summary_of_published_data_4-4" class="reference"><a href="#cite_note-Neuroferritinopathy-_Summary_of_published_data-4"><span class="cite-bracket">[</span>4<span class="cite-bracket">]</span></a></sup> Patients who are diagnosed with neuroferritinopathy have abnormal iron accumulation in the brain within the <a href="/wiki/Neurons" class="mw-redirect" title="Neurons">neurons</a> and <a href="/wiki/Glia" title="Glia">glia</a> of the <a href="/wiki/Striatum" title="Striatum">striatum</a> and cerebellar cortices.<sup id="cite_ref-Zecca_3-1" class="reference"><a href="#cite_note-Zecca-3"><span class="cite-bracket">[</span>3<span class="cite-bracket">]</span></a></sup> Along with the accumulation of iron in the brain, neuroferritinopathy typically causes severe neuronal loss as well.<sup id="cite_ref-Zecca_3-2" class="reference"><a href="#cite_note-Zecca-3"><span class="cite-bracket">[</span>3<span class="cite-bracket">]</span></a></sup> Secondary symptoms may also arise. It is possible that the initial iron accumulation will cause additional neuronal damage and neuronal death.<sup id="cite_ref-Zecca_3-3" class="reference"><a href="#cite_note-Zecca-3"><span class="cite-bracket">[</span>3<span class="cite-bracket">]</span></a></sup> The damaged neurons may be replaced by other cells in an effort to reverse the neurodegeneration. These cells often have a higher iron content. The breakdown of the <a href="/wiki/Blood_brain_barrier" class="mw-redirect" title="Blood brain barrier">blood brain barrier</a> may also occur due to the loss of neurons and will subsequently allow more iron to access the brain and accumulate over time.<sup id="cite_ref-Zecca_3-4" class="reference"><a href="#cite_note-Zecca-3"><span class="cite-bracket">[</span>3<span class="cite-bracket">]</span></a></sup> </p><p>Neuroferritinopathy is mainly seen in those who have reached late adulthood and is generally seen to slowly progress throughout many decades in a lifetime with the mean age of onset being 39 years old.<sup id="cite_ref-Neuroferritinopathy-Current_understanding_review_1-1" class="reference"><a href="#cite_note-Neuroferritinopathy-Current_understanding_review-1"><span class="cite-bracket">[</span>1<span class="cite-bracket">]</span></a></sup> A loss of cognition is generally only seen with late stages of the disease.<sup id="cite_ref-Neuroferritinopathy-Current_understanding_review_1-2" class="reference"><a href="#cite_note-Neuroferritinopathy-Current_understanding_review-1"><span class="cite-bracket">[</span>1<span class="cite-bracket">]</span></a></sup> Diagnosed patients are seen to retain most of their cognitive functioning until the most progressive stages of the illness sets in.<sup id="cite_ref-Neuroferritinopathy-Current_understanding_review_1-3" class="reference"><a href="#cite_note-Neuroferritinopathy-Current_understanding_review-1"><span class="cite-bracket">[</span>1<span class="cite-bracket">]</span></a></sup> </p> <div class="mw-heading mw-heading3"><h3 id="Physical_symptoms">Physical symptoms</h3><span class="mw-editsection"> <a role="button" href="/w/index.php?title=Neuroferritinopathy&amp;action=edit&amp;section=3" title="Edit section: Physical symptoms" class="cdx-button cdx-button--size-large cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--icon-only cdx-button--weight-quiet "> <span class="minerva-icon minerva-icon--edit"></span> <span>edit</span> </a> </span> </div> <p>Symptoms categorized as physically visible symptoms include <a href="/wiki/Chorea" title="Chorea">chorea</a>, <a href="/wiki/Dystonia" title="Dystonia">dystonia</a>, <a href="/wiki/Spasticity" title="Spasticity">spasticity</a>, and <a href="/wiki/Rigidity_(neurology)" class="mw-redirect" title="Rigidity (neurology)">rigidity</a>, all physical symptoms of the body associated with <a href="/wiki/Movement_disorders" class="mw-redirect" title="Movement disorders">movement disorders</a>.<sup id="cite_ref-Zecca_3-5" class="reference"><a href="#cite_note-Zecca-3"><span class="cite-bracket">[</span>3<span class="cite-bracket">]</span></a></sup> The symptoms accompanying neuroferritinopathy affecting movement are also progressive, becoming more generalized with time.<sup id="cite_ref-Neuroferritinopathy-_Summary_of_published_data_4-5" class="reference"><a href="#cite_note-Neuroferritinopathy-_Summary_of_published_data-4"><span class="cite-bracket">[</span>4<span class="cite-bracket">]</span></a></sup> Usually during the first ten years of onset of the disease only one or two limbs are directly affected.<sup id="cite_ref-Neuroferritinopathy-_Summary_of_published_data_4-6" class="reference"><a href="#cite_note-Neuroferritinopathy-_Summary_of_published_data-4"><span class="cite-bracket">[</span>4<span class="cite-bracket">]</span></a></sup> Distinctive symptoms of neuroferritinopathy are chorea, found in 50% of diagnosed patients, dystonia, found in 43% of patients, and <a href="/wiki/Parkinsonism" title="Parkinsonism">parkinsonism</a>, found in 7.5% of patients.<sup id="cite_ref-Neuroferritinopathy-Current_understanding_review_1-4" class="reference"><a href="#cite_note-Neuroferritinopathy-Current_understanding_review-1"><span class="cite-bracket">[</span>1<span class="cite-bracket">]</span></a></sup> Full control of upper limbs on the body generally remains until late onset of the disease.<sup id="cite_ref-Neuroferritinopathy-Current_understanding_review_1-5" class="reference"><a href="#cite_note-Neuroferritinopathy-Current_understanding_review-1"><span class="cite-bracket">[</span>1<span class="cite-bracket">]</span></a></sup> Over time, symptoms seen in a patient can change from one side of the body to the opposite side of the body, jumping from left to right or vice versa.<sup id="cite_ref-Neuroferritinopathy-Current_understanding_review_1-6" class="reference"><a href="#cite_note-Neuroferritinopathy-Current_understanding_review-1"><span class="cite-bracket">[</span>1<span class="cite-bracket">]</span></a></sup> Another route that the physically visible symptoms have been observed to take is the appearance, disappearance, and then reappearance once more of specific symptoms.<sup id="cite_ref-Neuroferritinopathy-Current_understanding_review_1-7" class="reference"><a href="#cite_note-Neuroferritinopathy-Current_understanding_review-1"><span class="cite-bracket">[</span>1<span class="cite-bracket">]</span></a></sup> </p><p>While these symptoms are the classic indicators of neuroferritinopathy, symptoms will vary from patient to patient.<sup id="cite_ref-Neuroferritinopathy-Current_understanding_review_1-8" class="reference"><a href="#cite_note-Neuroferritinopathy-Current_understanding_review-1"><span class="cite-bracket">[</span>1<span class="cite-bracket">]</span></a></sup> </p> </section><div class="mw-heading mw-heading2 section-heading" onclick="mfTempOpenSection(2)"><span class="indicator mf-icon mf-icon-expand mf-icon--small"></span><h2 id="Causes">Causes</h2><span class="mw-editsection"> <a role="button" href="/w/index.php?title=Neuroferritinopathy&amp;action=edit&amp;section=4" title="Edit section: Causes" class="cdx-button cdx-button--size-large cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--icon-only cdx-button--weight-quiet "> <span class="minerva-icon minerva-icon--edit"></span> <span>edit</span> </a> </span> </div><section class="mf-section-2 collapsible-block" id="mf-section-2"> <p>Neuroferritinopathy results from abnormal brain iron accumulation. This iron accumulation is due to mutations in the FTL polypeptide, which is responsible for encoding proteins involved in iron metabolism. Neuroferritinopathy is most commonly caused by a single insertion of the nucleotide adenine into the gene for L-chain ferritin which in turn, alters the <a href="/wiki/Carboxylic_acid" title="Carboxylic acid">carboxyl</a> end of the entire protein chain.<sup id="cite_ref-Zecca_3-6" class="reference"><a href="#cite_note-Zecca-3"><span class="cite-bracket">[</span>3<span class="cite-bracket">]</span></a></sup> However, exact location of the insertion in the <a href="/wiki/Exon" title="Exon">exon</a> varies by family.<sup id="cite_ref-Neuroferritinopathy-_Summary_of_published_data_4-7" class="reference"><a href="#cite_note-Neuroferritinopathy-_Summary_of_published_data-4"><span class="cite-bracket">[</span>4<span class="cite-bracket">]</span></a></sup> Neuroferritinopathy may also be caused by the insertion of two extra nucleotide bases. The insertion of bases into the L-chain ferritin gene causes the chain to lengthen and alter the sequence of the amino acids found in the gene, also known as a <a href="/wiki/Frameshift_mutation" title="Frameshift mutation">frameshift mutation</a>.<sup id="cite_ref-Zecca_3-7" class="reference"><a href="#cite_note-Zecca-3"><span class="cite-bracket">[</span>3<span class="cite-bracket">]</span></a></sup> </p><p>These mutations result in decreased iron-binding ability.<sup id="cite_ref-Neuroferritinopathy-Current_understanding_review_1-9" class="reference"><a href="#cite_note-Neuroferritinopathy-Current_understanding_review-1"><span class="cite-bracket">[</span>1<span class="cite-bracket">]</span></a></sup> The oxidative damage caused by increased iron leads to <a href="/wiki/Apoptosis" title="Apoptosis">apoptosis</a>, or programmed cell death.<sup id="cite_ref-Neuroferritinopathy-Current_understanding_review_1-10" class="reference"><a href="#cite_note-Neuroferritinopathy-Current_understanding_review-1"><span class="cite-bracket">[</span>1<span class="cite-bracket">]</span></a></sup> Accumulation of iron in the brain is extremely dangerous as excess iron catalyzes the formation of <a href="/wiki/Radical_surgery" title="Radical surgery">free radicals</a>, which have damaging effects to the brain.<sup id="cite_ref-Neuroferritinopathy-Current_understanding_review_1-11" class="reference"><a href="#cite_note-Neuroferritinopathy-Current_understanding_review-1"><span class="cite-bracket">[</span>1<span class="cite-bracket">]</span></a></sup> The iron accumulation characteristic of neuroferritinopathy particularly affects the cerebellum, basal ganglia, and motor cortex regions of the brain.<sup id="cite_ref-Neuroferritinopathy-Current_understanding_review_1-12" class="reference"><a href="#cite_note-Neuroferritinopathy-Current_understanding_review-1"><span class="cite-bracket">[</span>1<span class="cite-bracket">]</span></a></sup> </p> </section><div class="mw-heading mw-heading2 section-heading" onclick="mfTempOpenSection(3)"><span class="indicator mf-icon mf-icon-expand mf-icon--small"></span><h2 id="Mechanism">Mechanism</h2><span class="mw-editsection"> <a role="button" href="/w/index.php?title=Neuroferritinopathy&amp;action=edit&amp;section=5" title="Edit section: Mechanism" class="cdx-button cdx-button--size-large cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--icon-only cdx-button--weight-quiet "> <span class="minerva-icon minerva-icon--edit"></span> <span>edit</span> </a> </span> </div><section class="mf-section-3 collapsible-block" id="mf-section-3"> <p>The protein <a href="/wiki/Ferritin" title="Ferritin">ferritin</a> functions to sequester and release iron, acting as an iron buffering system in cells. Iron is essential to brain function in oxygen transport and cellular metabolism for example. However, careful control of iron is important as increased brain iron levels catalyze the formation of <a href="/wiki/Radical_(chemistry)" title="Radical (chemistry)">free radicals</a> that create oxidative molecules via the <a href="/wiki/Fenton%27s_reagent" title="Fenton's reagent">Fenton Reaction</a>.<sup id="cite_ref-5" class="reference"><a href="#cite_note-5"><span class="cite-bracket">[</span>5<span class="cite-bracket">]</span></a></sup> These oxidative molecules can cause oxidative brain damage. Iron that is bound to ferritin in nonreactive.<sup id="cite_ref-Neuroferritinopathy-Current_understanding_review_1-13" class="reference"><a href="#cite_note-Neuroferritinopathy-Current_understanding_review-1"><span class="cite-bracket">[</span>1<span class="cite-bracket">]</span></a></sup> </p><p>Fenton Reaction </p><p>(1) Fe<sup>2+</sup> + H<sub>2</sub>O<sub>2</sub> → Fe<sup>3+</sup> + HO• + OH<sup>−</sup> </p><p>(2) Fe<sup>3+</sup> + H<sub>2</sub>O<sub>2</sub> → Fe<sup>2+</sup> + HOO• + H<sup>+</sup> </p><p>The ferritin protein is made up of <a href="/wiki/FTH1" title="FTH1">heavy chain (H)</a> and <a href="/wiki/Ferritin_light_chain" title="Ferritin light chain">light chain (L)</a> subunits. In neuroferritinopathy, the gene encoding the light chain is mutated. Several different mutation variations have led to diagnosis as neuroferritinopathy; all of these mutations occur in the light chain. A mutated light chain is believed to inhibit ferritin's ability to effectively sequester and hold iron. Without control of iron, it is free to cause oxidative brain damage as described above.<sup id="cite_ref-CNS_Metabolism_of_Iron_6-0" class="reference"><a href="#cite_note-CNS_Metabolism_of_Iron-6"><span class="cite-bracket">[</span>6<span class="cite-bracket">]</span></a></sup> </p><p>The concentration of iron in a healthy brain varies greatly from region to region. The specific regions of the brain that are associated with motor functions appear to have larger accumulations of iron than non-motor-related regions. This observation of varying iron concentrations is a possible explanation for the correlation between movement disorders and the iron imbalance within the central nervous system.<sup id="cite_ref-Zecca_3-8" class="reference"><a href="#cite_note-Zecca-3"><span class="cite-bracket">[</span>3<span class="cite-bracket">]</span></a></sup> </p> </section><div class="mw-heading mw-heading2 section-heading" onclick="mfTempOpenSection(4)"><span class="indicator mf-icon mf-icon-expand mf-icon--small"></span><h2 id="Diagnosis">Diagnosis</h2><span class="mw-editsection"> <a role="button" href="/w/index.php?title=Neuroferritinopathy&amp;action=edit&amp;section=6" title="Edit section: Diagnosis" class="cdx-button cdx-button--size-large cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--icon-only cdx-button--weight-quiet "> <span class="minerva-icon minerva-icon--edit"></span> <span>edit</span> </a> </span> </div><section class="mf-section-4 collapsible-block" id="mf-section-4"> <p>Neuroferritinopathy is primarily diagnosed in older adults, specifically in adults affected by <a href="/wiki/Alzheimer%27s_disease" title="Alzheimer's disease">Alzheimer's disease</a> or <a href="/wiki/Parkinson%27s_disease" title="Parkinson's disease">Parkinson's disease</a>, as iron accumulates in the brain over long periods of time.<sup id="cite_ref-Zecca_3-9" class="reference"><a href="#cite_note-Zecca-3"><span class="cite-bracket">[</span>3<span class="cite-bracket">]</span></a></sup> Neuroferritinopathy is diagnosed using either neuroimaging techniques, physiological tests, or <a href="/wiki/Genetic_testing" title="Genetic testing">genetic testing</a>. </p> <div class="mw-heading mw-heading3"><h3 id="Classification">Classification</h3><span class="mw-editsection"> <a role="button" href="/w/index.php?title=Neuroferritinopathy&amp;action=edit&amp;section=7" title="Edit section: Classification" class="cdx-button cdx-button--size-large cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--icon-only cdx-button--weight-quiet "> <span class="minerva-icon minerva-icon--edit"></span> <span>edit</span> </a> </span> </div> <p>Neuroferritinopathy was originally described with hallmark features of neurodegeneration and iron accumulation in the brain, leading it to be classified with other <a href="/wiki/Neurodegeneration_with_brain_iron_accumulation" title="Neurodegeneration with brain iron accumulation">neurodegeneration with brain iron accumulation</a> (NBIA) disorders which share similar symptoms and imaging findings. Over time single-gene causes have been found for many NBIA disorders, like neuroferritinopathy. Before the availability of genetic testing, all such disorders were considered together and known as Hallervorden-Spatz syndrome, a term which is no longer used due to the <a href="/wiki/Nazi_party" class="mw-redirect" title="Nazi party">Nazi party</a> ties of the namesakes.<sup id="cite_ref-Neuroferritinopathy-Current_understanding_review_1-14" class="reference"><a href="#cite_note-Neuroferritinopathy-Current_understanding_review-1"><span class="cite-bracket">[</span>1<span class="cite-bracket">]</span></a></sup> Brain iron disorders are now divided into three categories: <a href="/wiki/Neurodegeneration_with_brain_iron_accumulation" title="Neurodegeneration with brain iron accumulation">genetic neurodegeneration with brain iron accumulation</a>, genetic systemic iron accumulation with neurologic features, and acquired diseases associated with iron excess or iron deficiency. Neuroferritinopathy is classified under the first category.<sup id="cite_ref-7" class="reference"><a href="#cite_note-7"><span class="cite-bracket">[</span>7<span class="cite-bracket">]</span></a></sup> Neuroferritinopathy is classified as a late-onset <a href="/wiki/Basal_ganglia" title="Basal ganglia">basal ganglia</a> disease and is a dominantly inherited neurodegenerative disease.<sup id="cite_ref-Zecca_3-10" class="reference"><a href="#cite_note-Zecca-3"><span class="cite-bracket">[</span>3<span class="cite-bracket">]</span></a></sup> Four different <a href="/wiki/Allele" title="Allele">alleles</a> are responsible for neuroferritinopathy. Three arise from <a href="/wiki/Nucleotide" title="Nucleotide">nucleotide</a> insertions in the <a href="/wiki/Ferritin_light_chain" title="Ferritin light chain">ferritin light chain</a> (FTL) polypeptide gene while the fourth arises from a missense mutation in the FTL gene.<sup id="cite_ref-Neuroferritinopathy-_Summary_of_published_data_4-8" class="reference"><a href="#cite_note-Neuroferritinopathy-_Summary_of_published_data-4"><span class="cite-bracket">[</span>4<span class="cite-bracket">]</span></a></sup> </p> <div class="mw-heading mw-heading3"><h3 id="Neuroimaging">Neuroimaging</h3><span class="mw-editsection"> <a role="button" href="/w/index.php?title=Neuroferritinopathy&amp;action=edit&amp;section=8" title="Edit section: Neuroimaging" class="cdx-button cdx-button--size-large cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--icon-only cdx-button--weight-quiet "> <span class="minerva-icon minerva-icon--edit"></span> <span>edit</span> </a> </span> </div> <figure class="mw-default-size" typeof="mw:File/Thumb"><a href="/wiki/File:NPH_MRI_274.gif" class="mw-file-description"><noscript><img src="//upload.wikimedia.org/wikipedia/commons/thumb/d/de/NPH_MRI_274.gif/220px-NPH_MRI_274.gif" decoding="async" width="220" height="220" class="mw-file-element" data-file-width="512" data-file-height="512"></noscript><span class="lazy-image-placeholder" style="width: 220px;height: 220px;" data-src="//upload.wikimedia.org/wikipedia/commons/thumb/d/de/NPH_MRI_274.gif/220px-NPH_MRI_274.gif" data-width="220" data-height="220" data-srcset="//upload.wikimedia.org/wikipedia/commons/thumb/d/de/NPH_MRI_274.gif/330px-NPH_MRI_274.gif 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/d/de/NPH_MRI_274.gif/440px-NPH_MRI_274.gif 2x" data-class="mw-file-element">&nbsp;</span></a><figcaption>MRI</figcaption></figure> <p>Neuroferritinopathy is most commonly diagnosed using <a href="/wiki/Magnetic_resonance_imaging" title="Magnetic resonance imaging">MRI</a> and other neuroimaging techniques.<sup id="cite_ref-Neuroferritinopathy-Current_understanding_review_1-15" class="reference"><a href="#cite_note-Neuroferritinopathy-Current_understanding_review-1"><span class="cite-bracket">[</span>1<span class="cite-bracket">]</span></a></sup> MRIs help identify the iron deposits in the cerebellum, basal ganglia, and motor cortex common to neuroferritinopathy.<sup id="cite_ref-Update_on_path_mechanisms_Levi_8-0" class="reference"><a href="#cite_note-Update_on_path_mechanisms_Levi-8"><span class="cite-bracket">[</span>8<span class="cite-bracket">]</span></a></sup> MRIs of affected individuals also show mild cerebellar and <a href="/wiki/Cerebral_atrophy" title="Cerebral atrophy">cerebral atrophy</a>, or tissue breakdown, and gas cavity formation in the <a href="/wiki/Putamen" title="Putamen">putamen</a>.<sup id="cite_ref-Update_on_path_mechanisms_Levi_8-1" class="reference"><a href="#cite_note-Update_on_path_mechanisms_Levi-8"><span class="cite-bracket">[</span>8<span class="cite-bracket">]</span></a></sup> Most importantly, the MRIs show misfolded ferritin proteins and iron deposits in the glial cells of the caudate, putamen, globus pallidus, cerebral cortex, thalamus, and <a href="/wiki/Purkinje_cells" class="mw-redirect" title="Purkinje cells">purkinje cells</a>, causing neuronal death in these areas.<sup id="cite_ref-Update_on_path_mechanisms_Levi_8-2" class="reference"><a href="#cite_note-Update_on_path_mechanisms_Levi-8"><span class="cite-bracket">[</span>8<span class="cite-bracket">]</span></a></sup> </p> <div class="mw-heading mw-heading3"><h3 id="Physiological_testing">Physiological testing</h3><span class="mw-editsection"> <a role="button" href="/w/index.php?title=Neuroferritinopathy&amp;action=edit&amp;section=9" title="Edit section: Physiological testing" class="cdx-button cdx-button--size-large cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--icon-only cdx-button--weight-quiet "> <span class="minerva-icon minerva-icon--edit"></span> <span>edit</span> </a> </span> </div> <p>Blood tests usually come back normal in affected individuals so they do not serve as a reliable means of diagnosis.<sup id="cite_ref-Neuroferritinopathy-Current_understanding_review_1-16" class="reference"><a href="#cite_note-Neuroferritinopathy-Current_understanding_review-1"><span class="cite-bracket">[</span>1<span class="cite-bracket">]</span></a></sup> Blood tests can show low <a href="/wiki/Serum_(blood)" title="Serum (blood)">serum</a> ferritin levels. However this is unreliable as method of diagnosis since some patients show typical serum ferritin levels even at the latest stages of neuroferritinopathy.<sup id="cite_ref-Neuroferritinopathy-Current_understanding_review_1-17" class="reference"><a href="#cite_note-Neuroferritinopathy-Current_understanding_review-1"><span class="cite-bracket">[</span>1<span class="cite-bracket">]</span></a></sup> Cerebral spinal fluid tests also are typically normal.<sup id="cite_ref-Update_on_path_mechanisms_Levi_8-3" class="reference"><a href="#cite_note-Update_on_path_mechanisms_Levi-8"><span class="cite-bracket">[</span>8<span class="cite-bracket">]</span></a></sup> Ferritin <a href="https://en.wiktionary.org/wiki/Special:Search/aggregate" class="extiw" title="wikt:Special:Search/aggregate">aggregates</a> found in the skin, liver, kidney and muscle tissues may help in diagnosing neuroferritinopathy.<sup id="cite_ref-Update_on_path_mechanisms_Levi_8-4" class="reference"><a href="#cite_note-Update_on_path_mechanisms_Levi-8"><span class="cite-bracket">[</span>8<span class="cite-bracket">]</span></a></sup> More <a href="/wiki/Cytochrome_c_oxidase" title="Cytochrome c oxidase">cytochrome c oxidase</a>-negative fibers are also often found in the muscle <a href="/wiki/Biopsies" class="mw-redirect" title="Biopsies">biopsies</a> of affected individuals.<sup id="cite_ref-Update_on_path_mechanisms_Levi_8-5" class="reference"><a href="#cite_note-Update_on_path_mechanisms_Levi-8"><span class="cite-bracket">[</span>8<span class="cite-bracket">]</span></a></sup> </p> <div class="mw-heading mw-heading3"><h3 id="Genetic_testing">Genetic testing</h3><span class="mw-editsection"> <a role="button" href="/w/index.php?title=Neuroferritinopathy&amp;action=edit&amp;section=10" title="Edit section: Genetic testing" class="cdx-button cdx-button--size-large cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--icon-only cdx-button--weight-quiet "> <span class="minerva-icon minerva-icon--edit"></span> <span>edit</span> </a> </span> </div> <p>Genetic testing can confirm a neuroferritinopathy diagnosis. A diagnosis can be made by analyzing the protein sequences of affected individuals and comparing them to known neuroferritinopathy sequences.<sup id="cite_ref-Neuroferritinopathy-_Summary_of_published_data_4-9" class="reference"><a href="#cite_note-Neuroferritinopathy-_Summary_of_published_data-4"><span class="cite-bracket">[</span>4<span class="cite-bracket">]</span></a></sup> </p> </section><div class="mw-heading mw-heading2 section-heading" onclick="mfTempOpenSection(5)"><span class="indicator mf-icon mf-icon-expand mf-icon--small"></span><h2 id="Treatment">Treatment</h2><span class="mw-editsection"> <a role="button" href="/w/index.php?title=Neuroferritinopathy&amp;action=edit&amp;section=11" title="Edit section: Treatment" class="cdx-button cdx-button--size-large cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--icon-only cdx-button--weight-quiet "> <span class="minerva-icon minerva-icon--edit"></span> <span>edit</span> </a> </span> </div><section class="mf-section-5 collapsible-block" id="mf-section-5"> <p>Due to neuroferritinopathy's genetic etiology, the disorder is not currently curable. Furthermore, progression of the disorder cannot be effectively halted.<sup id="cite_ref-Neuroferritinopathy-Current_understanding_review_1-18" class="reference"><a href="#cite_note-Neuroferritinopathy-Current_understanding_review-1"><span class="cite-bracket">[</span>1<span class="cite-bracket">]</span></a></sup> Therefore current treatment focuses on managing symptoms of the disorder. No medication is available to treat all symptoms.<sup id="cite_ref-Neuroferritinopathy-Current_understanding_review_1-19" class="reference"><a href="#cite_note-Neuroferritinopathy-Current_understanding_review-1"><span class="cite-bracket">[</span>1<span class="cite-bracket">]</span></a></sup> <a href="/wiki/Botulinum_Toxin" class="mw-redirect" title="Botulinum Toxin">Botox</a> has been shown to help with focal dystonia.<sup id="cite_ref-Neuroferritinopathy-Current_understanding_review_1-20" class="reference"><a href="#cite_note-Neuroferritinopathy-Current_understanding_review-1"><span class="cite-bracket">[</span>1<span class="cite-bracket">]</span></a></sup> The dopamine depleter <a href="/wiki/Tetrabenazine" title="Tetrabenazine">Tetrabenazine</a> shown to help with involuntary movements.<sup id="cite_ref-Neuroferritinopathy-Current_understanding_review_1-21" class="reference"><a href="#cite_note-Neuroferritinopathy-Current_understanding_review-1"><span class="cite-bracket">[</span>1<span class="cite-bracket">]</span></a></sup> Symptoms affecting movement (dystonia) have also been treated with <a href="/wiki/L-Dopa" class="mw-redirect" title="L-Dopa">L-Dopa</a>, <a href="/wiki/Orphenadrine" title="Orphenadrine">orphenadrine</a>, <a href="/wiki/Benzhexol" class="mw-redirect" title="Benzhexol">benzhexol</a>, <a href="/wiki/Sulpiride" title="Sulpiride">sulpiride</a>, <a href="/wiki/Diazepam" title="Diazepam">diazepam</a>, <a href="/wiki/Clonazepam" title="Clonazepam">clonazepam</a>, and <a href="/wiki/Deanol" class="mw-redirect" title="Deanol">deanol</a>.<sup id="cite_ref-Neuroferritinopathy-_Summary_of_published_data_4-10" class="reference"><a href="#cite_note-Neuroferritinopathy-_Summary_of_published_data-4"><span class="cite-bracket">[</span>4<span class="cite-bracket">]</span></a></sup> Parkinsonian symptoms were not decreased by <a href="/wiki/L-Dopa" class="mw-redirect" title="L-Dopa">L-Dopa</a>.<sup id="cite_ref-Neuroferritinopathy-Current_understanding_review_1-22" class="reference"><a href="#cite_note-Neuroferritinopathy-Current_understanding_review-1"><span class="cite-bracket">[</span>1<span class="cite-bracket">]</span></a></sup> Iron supplements should be avoided.<sup id="cite_ref-Neuroferritinopathy-_Summary_of_published_data_4-11" class="reference"><a href="#cite_note-Neuroferritinopathy-_Summary_of_published_data-4"><span class="cite-bracket">[</span>4<span class="cite-bracket">]</span></a></sup> </p> </section><div class="mw-heading mw-heading2 section-heading" onclick="mfTempOpenSection(6)"><span class="indicator mf-icon mf-icon-expand mf-icon--small"></span><h2 id="Epidemiology">Epidemiology</h2><span class="mw-editsection"> <a role="button" href="/w/index.php?title=Neuroferritinopathy&amp;action=edit&amp;section=12" title="Edit section: Epidemiology" class="cdx-button cdx-button--size-large cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--icon-only cdx-button--weight-quiet "> <span class="minerva-icon minerva-icon--edit"></span> <span>edit</span> </a> </span> </div><section class="mf-section-6 collapsible-block" id="mf-section-6"> <figure class="mw-default-size" typeof="mw:File/Thumb"><a href="/wiki/File:English_regions_2009_(named).svg" class="mw-file-description"><noscript><img src="//upload.wikimedia.org/wikipedia/commons/thumb/c/cb/English_regions_2009_%28named%29.svg/220px-English_regions_2009_%28named%29.svg.png" decoding="async" width="220" height="267" class="mw-file-element" data-file-width="1108" data-file-height="1345"></noscript><span class="lazy-image-placeholder" style="width: 220px;height: 267px;" data-src="//upload.wikimedia.org/wikipedia/commons/thumb/c/cb/English_regions_2009_%28named%29.svg/220px-English_regions_2009_%28named%29.svg.png" data-width="220" data-height="267" data-srcset="//upload.wikimedia.org/wikipedia/commons/thumb/c/cb/English_regions_2009_%28named%29.svg/330px-English_regions_2009_%28named%29.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/c/cb/English_regions_2009_%28named%29.svg/440px-English_regions_2009_%28named%29.svg.png 2x" data-class="mw-file-element">&nbsp;</span></a><figcaption>Map of England</figcaption></figure> <p>Neuroferritinopathy was first discovered in 2001, with its first case being reported in Cumbria from Northern England.<sup id="cite_ref-Neuroferritinopathy-Current_understanding_review_1-23" class="reference"><a href="#cite_note-Neuroferritinopathy-Current_understanding_review-1"><span class="cite-bracket">[</span>1<span class="cite-bracket">]</span></a></sup> The discovery of neuroferritinopathy was mediated by a study done on a large family suffering from a dominantly inherited basal ganglia disease.<sup id="cite_ref-Neuroferritinopathy-Current_understanding_review_1-24" class="reference"><a href="#cite_note-Neuroferritinopathy-Current_understanding_review-1"><span class="cite-bracket">[</span>1<span class="cite-bracket">]</span></a></sup> It was reported that the disease was instigated by a mutation on the ferritin light chain polypeptide (FTL1) and was found to cause iron accumulation in the brain and neurodegeneration.<sup id="cite_ref-Neuroferritinopathy-Current_understanding_review_1-25" class="reference"><a href="#cite_note-Neuroferritinopathy-Current_understanding_review-1"><span class="cite-bracket">[</span>1<span class="cite-bracket">]</span></a></sup> Following the location of the first case of Neuroferritinopathy, the majority of patients diagnosed with the disease have also been found in Northern and Northeast England.<sup id="cite_ref-Neuroferritinopathy-Current_understanding_review_1-26" class="reference"><a href="#cite_note-Neuroferritinopathy-Current_understanding_review-1"><span class="cite-bracket">[</span>1<span class="cite-bracket">]</span></a></sup> The localization of the majority of cases to Northern and Northeast England suggests that a common ancestor may be responsible for many or possibly all cases.<sup id="cite_ref-Neuroferritinopathy-_Summary_of_published_data_4-12" class="reference"><a href="#cite_note-Neuroferritinopathy-_Summary_of_published_data-4"><span class="cite-bracket">[</span>4<span class="cite-bracket">]</span></a></sup> Despite there being fewer than 100 cases reported and the disease's general location of Northern and Northeast England, many more cases of neuroferritinopathy have been diagnosed around the rest of the world in recent years.<sup id="cite_ref-Neuroferritinopathy-_Summary_of_published_data_4-13" class="reference"><a href="#cite_note-Neuroferritinopathy-_Summary_of_published_data-4"><span class="cite-bracket">[</span>4<span class="cite-bracket">]</span></a></sup> </p> </section><div class="mw-heading mw-heading2 section-heading" onclick="mfTempOpenSection(7)"><span class="indicator mf-icon mf-icon-expand mf-icon--small"></span><h2 id="Research">Research</h2><span class="mw-editsection"> <a role="button" href="/w/index.php?title=Neuroferritinopathy&amp;action=edit&amp;section=13" title="Edit section: Research" class="cdx-button cdx-button--size-large cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--icon-only cdx-button--weight-quiet "> <span class="minerva-icon minerva-icon--edit"></span> <span>edit</span> </a> </span> </div><section class="mf-section-7 collapsible-block" id="mf-section-7"> <p>New potential treatment options being researched are Venesection (removing red blood cells), Iron chelation with <a href="/wiki/Deferiprone" title="Deferiprone">deferiprone</a>, and <a href="/wiki/Coenzyme_Q10" title="Coenzyme Q10">Coenzyme Q10 (ubiquinone)</a>.<sup id="cite_ref-Neuroferritinopathy-_Summary_of_published_data_4-14" class="reference"><a href="#cite_note-Neuroferritinopathy-_Summary_of_published_data-4"><span class="cite-bracket">[</span>4<span class="cite-bracket">]</span></a></sup> </p> </section><div class="mw-heading mw-heading2 section-heading" onclick="mfTempOpenSection(8)"><span class="indicator mf-icon mf-icon-expand mf-icon--small"></span><h2 id="References">References</h2><span class="mw-editsection"> <a role="button" href="/w/index.php?title=Neuroferritinopathy&amp;action=edit&amp;section=14" title="Edit section: References" class="cdx-button cdx-button--size-large cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--icon-only cdx-button--weight-quiet "> <span class="minerva-icon minerva-icon--edit"></span> <span>edit</span> </a> </span> </div><section class="mf-section-8 collapsible-block" id="mf-section-8"> <style data-mw-deduplicate="TemplateStyles:r1239543626">.mw-parser-output .reflist{margin-bottom:0.5em;list-style-type:decimal}@media screen{.mw-parser-output .reflist{font-size:90%}}.mw-parser-output .reflist .references{font-size:100%;margin-bottom:0;list-style-type:inherit}.mw-parser-output .reflist-columns-2{column-width:30em}.mw-parser-output .reflist-columns-3{column-width:25em}.mw-parser-output .reflist-columns{margin-top:0.3em}.mw-parser-output .reflist-columns ol{margin-top:0}.mw-parser-output .reflist-columns li{page-break-inside:avoid;break-inside:avoid-column}.mw-parser-output .reflist-upper-alpha{list-style-type:upper-alpha}.mw-parser-output .reflist-upper-roman{list-style-type:upper-roman}.mw-parser-output .reflist-lower-alpha{list-style-type:lower-alpha}.mw-parser-output .reflist-lower-greek{list-style-type:lower-greek}.mw-parser-output .reflist-lower-roman{list-style-type:lower-roman}</style><div class="reflist"> <div class="mw-references-wrap"><ol class="references"> <li id="cite_note-Neuroferritinopathy-Current_understanding_review-1"><span class="mw-cite-backlink">^ <a href="#cite_ref-Neuroferritinopathy-Current_understanding_review_1-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Neuroferritinopathy-Current_understanding_review_1-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Neuroferritinopathy-Current_understanding_review_1-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Neuroferritinopathy-Current_understanding_review_1-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Neuroferritinopathy-Current_understanding_review_1-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Neuroferritinopathy-Current_understanding_review_1-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Neuroferritinopathy-Current_understanding_review_1-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Neuroferritinopathy-Current_understanding_review_1-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-Neuroferritinopathy-Current_understanding_review_1-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-Neuroferritinopathy-Current_understanding_review_1-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-Neuroferritinopathy-Current_understanding_review_1-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-Neuroferritinopathy-Current_understanding_review_1-11"><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-Neuroferritinopathy-Current_understanding_review_1-12"><sup><i><b>m</b></i></sup></a> <a href="#cite_ref-Neuroferritinopathy-Current_understanding_review_1-13"><sup><i><b>n</b></i></sup></a> <a href="#cite_ref-Neuroferritinopathy-Current_understanding_review_1-14"><sup><i><b>o</b></i></sup></a> <a href="#cite_ref-Neuroferritinopathy-Current_understanding_review_1-15"><sup><i><b>p</b></i></sup></a> <a href="#cite_ref-Neuroferritinopathy-Current_understanding_review_1-16"><sup><i><b>q</b></i></sup></a> <a href="#cite_ref-Neuroferritinopathy-Current_understanding_review_1-17"><sup><i><b>r</b></i></sup></a> <a href="#cite_ref-Neuroferritinopathy-Current_understanding_review_1-18"><sup><i><b>s</b></i></sup></a> <a href="#cite_ref-Neuroferritinopathy-Current_understanding_review_1-19"><sup><i><b>t</b></i></sup></a> <a href="#cite_ref-Neuroferritinopathy-Current_understanding_review_1-20"><sup><i><b>u</b></i></sup></a> <a href="#cite_ref-Neuroferritinopathy-Current_understanding_review_1-21"><sup><i><b>v</b></i></sup></a> <a href="#cite_ref-Neuroferritinopathy-Current_understanding_review_1-22"><sup><i><b>w</b></i></sup></a> <a href="#cite_ref-Neuroferritinopathy-Current_understanding_review_1-23"><sup><i><b>x</b></i></sup></a> <a href="#cite_ref-Neuroferritinopathy-Current_understanding_review_1-24"><sup><i><b>y</b></i></sup></a> <a href="#cite_ref-Neuroferritinopathy-Current_understanding_review_1-25"><sup><i><b>z</b></i></sup></a> <a href="#cite_ref-Neuroferritinopathy-Current_understanding_review_1-26"><sup><i><b>aa</b></i></sup></a></span> <span class="reference-text"><style data-mw-deduplicate="TemplateStyles:r1238218222">.mw-parser-output cite.citation{font-style:inherit;word-wrap:break-word}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .citation:target{background-color:rgba(0,127,255,0.133)}.mw-parser-output .id-lock-free.id-lock-free a{background:url("//upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-limited.id-lock-limited a,.mw-parser-output .id-lock-registration.id-lock-registration a{background:url("//upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-subscription.id-lock-subscription a{background:url("//upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .cs1-ws-icon a{background:url("//upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg")right 0.1em center/12px no-repeat}body:not(.skin-timeless):not(.skin-minerva) .mw-parser-output .id-lock-free a,body:not(.skin-timeless):not(.skin-minerva) .mw-parser-output .id-lock-limited a,body:not(.skin-timeless):not(.skin-minerva) .mw-parser-output .id-lock-registration a,body:not(.skin-timeless):not(.skin-minerva) .mw-parser-output .id-lock-subscription a,body:not(.skin-timeless):not(.skin-minerva) .mw-parser-output .cs1-ws-icon a{background-size:contain;padding:0 1em 0 0}.mw-parser-output .cs1-code{color:inherit;background:inherit;border:none;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;color:var(--color-error,#d33)}.mw-parser-output .cs1-visible-error{color:var(--color-error,#d33)}.mw-parser-output .cs1-maint{display:none;color:#085;margin-left:0.3em}.mw-parser-output .cs1-kern-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}@media screen{.mw-parser-output .cs1-format{font-size:95%}html.skin-theme-clientpref-night .mw-parser-output .cs1-maint{color:#18911f}}@media screen and (prefers-color-scheme:dark){html.skin-theme-clientpref-os .mw-parser-output .cs1-maint{color:#18911f}}</style><cite id="CITEREFLehnBoyleBrownAirey2012" class="citation journal cs1">Lehn, A; Boyle, R; Brown, H; Airey, C; Mellick, G (September 2012). "Neuroferritinopathy". <i>Parkinsonism &amp; Related Disorders</i>. <b>18</b> (8): 909–15. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.parkreldis.2012.06.021">10.1016/j.parkreldis.2012.06.021</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/22818529">22818529</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Parkinsonism+%26+Related+Disorders&amp;rft.atitle=Neuroferritinopathy&amp;rft.volume=18&amp;rft.issue=8&amp;rft.pages=909-15&amp;rft.date=2012-09&amp;rft_id=info%3Adoi%2F10.1016%2Fj.parkreldis.2012.06.021&amp;rft_id=info%3Apmid%2F22818529&amp;rft.aulast=Lehn&amp;rft.aufirst=A&amp;rft.au=Boyle%2C+R&amp;rft.au=Brown%2C+H&amp;rft.au=Airey%2C+C&amp;rft.au=Mellick%2C+G&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroferritinopathy" class="Z3988"></span></span> </li> <li id="cite_note-Comprehensive_Medical_Overview-2"><span class="mw-cite-backlink">^ <a href="#cite_ref-Comprehensive_Medical_Overview_2-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Comprehensive_Medical_Overview_2-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Comprehensive_Medical_Overview_2-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Comprehensive_Medical_Overview_2-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Comprehensive_Medical_Overview_2-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFChinneryPagonAdamArdinger2010" class="citation web cs1">Chinnery, PF; Pagon, RA; Adam, MP; Ardinger, HH; Bird, TD; Dolan, CR; Fong, CT; Smith, RJH; Stephens, K (2010). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/books/NBK1141/">"Neuroferritinopathy"</a>. University of Washington, Seattle. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/20301320">20301320</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Neuroferritinopathy&amp;rft.pub=University+of+Washington%2C+Seattle&amp;rft.date=2010&amp;rft_id=info%3Apmid%2F20301320&amp;rft.aulast=Chinnery&amp;rft.aufirst=PF&amp;rft.au=Pagon%2C+RA&amp;rft.au=Adam%2C+MP&amp;rft.au=Ardinger%2C+HH&amp;rft.au=Bird%2C+TD&amp;rft.au=Dolan%2C+CR&amp;rft.au=Fong%2C+CT&amp;rft.au=Smith%2C+RJH&amp;rft.au=Stephens%2C+K&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1141%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroferritinopathy" class="Z3988"></span></span> </li> <li id="cite_note-Zecca-3"><span class="mw-cite-backlink">^ <a href="#cite_ref-Zecca_3-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Zecca_3-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Zecca_3-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Zecca_3-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Zecca_3-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Zecca_3-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Zecca_3-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Zecca_3-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-Zecca_3-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-Zecca_3-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-Zecca_3-10"><sup><i><b>k</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFZeccaYoudimRiedererConnor2004" class="citation journal cs1">Zecca, L; Youdim, MB; Riederer, P; Connor, JR; Crichton, RR (November 2004). "Iron, brain ageing and neurodegenerative disorders". <i>Nature Reviews Neuroscience</i>. <b>5</b> (11): 863–73. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fnrn1537">10.1038/nrn1537</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/15496864">15496864</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:205500060">205500060</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews+Neuroscience&amp;rft.atitle=Iron%2C+brain+ageing+and+neurodegenerative+disorders&amp;rft.volume=5&amp;rft.issue=11&amp;rft.pages=863-73&amp;rft.date=2004-11&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A205500060%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F15496864&amp;rft_id=info%3Adoi%2F10.1038%2Fnrn1537&amp;rft.aulast=Zecca&amp;rft.aufirst=L&amp;rft.au=Youdim%2C+MB&amp;rft.au=Riederer%2C+P&amp;rft.au=Connor%2C+JR&amp;rft.au=Crichton%2C+RR&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroferritinopathy" class="Z3988"></span></span> </li> <li id="cite_note-Neuroferritinopathy-_Summary_of_published_data-4"><span class="mw-cite-backlink">^ <a href="#cite_ref-Neuroferritinopathy-_Summary_of_published_data_4-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Neuroferritinopathy-_Summary_of_published_data_4-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Neuroferritinopathy-_Summary_of_published_data_4-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Neuroferritinopathy-_Summary_of_published_data_4-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Neuroferritinopathy-_Summary_of_published_data_4-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Neuroferritinopathy-_Summary_of_published_data_4-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Neuroferritinopathy-_Summary_of_published_data_4-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Neuroferritinopathy-_Summary_of_published_data_4-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-Neuroferritinopathy-_Summary_of_published_data_4-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-Neuroferritinopathy-_Summary_of_published_data_4-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-Neuroferritinopathy-_Summary_of_published_data_4-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-Neuroferritinopathy-_Summary_of_published_data_4-11"><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-Neuroferritinopathy-_Summary_of_published_data_4-12"><sup><i><b>m</b></i></sup></a> <a href="#cite_ref-Neuroferritinopathy-_Summary_of_published_data_4-13"><sup><i><b>n</b></i></sup></a> <a href="#cite_ref-Neuroferritinopathy-_Summary_of_published_data_4-14"><sup><i><b>o</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFKeoghMorrisChinnery2013" class="citation journal cs1">Keogh, MJ; Morris, CM; Chinnery, PF (2013). "Neuroferritinopathy". <i>International Review of Neurobiology</i>. <b>110</b>: 91–123. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FB978-0-12-410502-7.00006-5">10.1016/B978-0-12-410502-7.00006-5</a>. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/9780124105027" title="Special:BookSources/9780124105027"><bdi>9780124105027</bdi></a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/24209436">24209436</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=International+Review+of+Neurobiology&amp;rft.atitle=Neuroferritinopathy.&amp;rft.volume=110&amp;rft.pages=91-123&amp;rft.date=2013&amp;rft_id=info%3Apmid%2F24209436&amp;rft_id=info%3Adoi%2F10.1016%2FB978-0-12-410502-7.00006-5&amp;rft.isbn=9780124105027&amp;rft.aulast=Keogh&amp;rft.aufirst=MJ&amp;rft.au=Morris%2C+CM&amp;rft.au=Chinnery%2C+PF&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroferritinopathy" class="Z3988"></span></span> </li> <li id="cite_note-5"><span class="mw-cite-backlink"><b><a href="#cite_ref-5">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFBatista-NascimentoPimentelAndrade_MenezesRodrigues-Pousada2012" class="citation journal cs1">Batista-Nascimento, Liliana; Pimentel, Catarina; Andrade Menezes, Regina; Rodrigues-Pousada, Claudina (2012). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3369498">"Iron and Neurodegeneration: From Cellular Homeostasis to Disease"</a>. <i>Oxidative Medicine and Cellular Longevity</i>. <b>2012</b>: 128647. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1155%2F2012%2F128647">10.1155/2012/128647</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3369498">3369498</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/22701145">22701145</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Oxidative+Medicine+and+Cellular+Longevity&amp;rft.atitle=Iron+and+Neurodegeneration%3A+From+Cellular+Homeostasis+to+Disease&amp;rft.volume=2012&amp;rft.pages=128647&amp;rft.date=2012&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3369498%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F22701145&amp;rft_id=info%3Adoi%2F10.1155%2F2012%2F128647&amp;rft.aulast=Batista-Nascimento&amp;rft.aufirst=Liliana&amp;rft.au=Pimentel%2C+Catarina&amp;rft.au=Andrade+Menezes%2C+Regina&amp;rft.au=Rodrigues-Pousada%2C+Claudina&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3369498&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroferritinopathy" class="Z3988"></span></span> </li> <li id="cite_note-CNS_Metabolism_of_Iron-6"><span class="mw-cite-backlink"><b><a href="#cite_ref-CNS_Metabolism_of_Iron_6-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFRouault2013" class="citation journal cs1">Rouault, Tracey A. (3 July 2013). <a rel="nofollow" class="external text" href="https://zenodo.org/record/1233568">"Iron metabolism in the CNS: implications for neurodegenerative diseases"</a>. <i>Nature Reviews Neuroscience</i>. <b>14</b> (8): 551–564. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fnrn3453">10.1038/nrn3453</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/23820773">23820773</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:21302204">21302204</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews+Neuroscience&amp;rft.atitle=Iron+metabolism+in+the+CNS%3A+implications+for+neurodegenerative+diseases&amp;rft.volume=14&amp;rft.issue=8&amp;rft.pages=551-564&amp;rft.date=2013-07-03&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A21302204%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F23820773&amp;rft_id=info%3Adoi%2F10.1038%2Fnrn3453&amp;rft.aulast=Rouault&amp;rft.aufirst=Tracey+A.&amp;rft_id=https%3A%2F%2Fzenodo.org%2Frecord%2F1233568&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroferritinopathy" class="Z3988"></span></span> </li> <li id="cite_note-7"><span class="mw-cite-backlink"><b><a href="#cite_ref-7">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFWoimantTrocello2014" class="citation book cs1">Woimant, F; Trocello, JM (2014). "Disorders of heavy metals". <i>Neurologic Aspects of Systemic Disease Part II</i>. Handbook of Clinical Neurology. Vol. 120. pp. 851–64. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FB978-0-7020-4087-0.00057-7">10.1016/B978-0-7020-4087-0.00057-7</a>. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/9780702040870" title="Special:BookSources/9780702040870"><bdi>9780702040870</bdi></a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/24365357">24365357</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Disorders+of+heavy+metals&amp;rft.btitle=Neurologic+Aspects+of+Systemic+Disease+Part+II&amp;rft.series=Handbook+of+Clinical+Neurology&amp;rft.pages=851-64&amp;rft.date=2014&amp;rft_id=info%3Apmid%2F24365357&amp;rft_id=info%3Adoi%2F10.1016%2FB978-0-7020-4087-0.00057-7&amp;rft.isbn=9780702040870&amp;rft.aulast=Woimant&amp;rft.aufirst=F&amp;rft.au=Trocello%2C+JM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroferritinopathy" class="Z3988"></span></span> </li> <li id="cite_note-Update_on_path_mechanisms_Levi-8"><span class="mw-cite-backlink">^ <a href="#cite_ref-Update_on_path_mechanisms_Levi_8-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Update_on_path_mechanisms_Levi_8-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Update_on_path_mechanisms_Levi_8-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Update_on_path_mechanisms_Levi_8-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Update_on_path_mechanisms_Levi_8-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Update_on_path_mechanisms_Levi_8-5"><sup><i><b>f</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFLeviFinazzi2014" class="citation journal cs1">Levi, Sonia; Finazzi, Dario (7 May 2014). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019866">"Neurodegeneration with brain iron accumulation: update on pathogenic mechanisms"</a>. <i>Frontiers in Pharmacology</i>. <b>5</b>: 99. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.3389%2Ffphar.2014.00099">10.3389/fphar.2014.00099</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019866">4019866</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/24847269">24847269</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Frontiers+in+Pharmacology&amp;rft.atitle=Neurodegeneration+with+brain+iron+accumulation%3A+update+on+pathogenic+mechanisms&amp;rft.volume=5&amp;rft.pages=99&amp;rft.date=2014-05-07&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4019866%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F24847269&amp;rft_id=info%3Adoi%2F10.3389%2Ffphar.2014.00099&amp;rft.aulast=Levi&amp;rft.aufirst=Sonia&amp;rft.au=Finazzi%2C+Dario&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4019866&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroferritinopathy" class="Z3988"></span></span> </li> </ol></div></div> </section><div class="mw-heading mw-heading2 section-heading" onclick="mfTempOpenSection(9)"><span class="indicator mf-icon mf-icon-expand mf-icon--small"></span><h2 id="External_links">External links</h2><span class="mw-editsection"> <a role="button" href="/w/index.php?title=Neuroferritinopathy&amp;action=edit&amp;section=15" title="Edit section: External links" class="cdx-button cdx-button--size-large cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--icon-only cdx-button--weight-quiet "> <span class="minerva-icon minerva-icon--edit"></span> <span>edit</span> </a> </span> </div><section class="mf-section-9 collapsible-block" id="mf-section-9"> <div class="navbox-styles"><style data-mw-deduplicate="TemplateStyles:r1236075235">.mw-parser-output .navbox{box-sizing:border-box;border:1px solid #a2a9b1;width:100%;clear:both;font-size:88%;text-align:center;padding:1px;margin:1em auto 0}.mw-parser-output .navbox .navbox{margin-top:0}.mw-parser-output .navbox+.navbox,.mw-parser-output .navbox+.navbox-styles+.navbox{margin-top:-1px}.mw-parser-output .navbox-inner,.mw-parser-output .navbox-subgroup{width:100%}.mw-parser-output .navbox-group,.mw-parser-output .navbox-title,.mw-parser-output .navbox-abovebelow{padding:0.25em 1em;line-height:1.5em;text-align:center}.mw-parser-output .navbox-group{white-space:nowrap;text-align:right}.mw-parser-output .navbox,.mw-parser-output .navbox-subgroup{background-color:#fdfdfd}.mw-parser-output .navbox-list{line-height:1.5em;border-color:#fdfdfd}.mw-parser-output .navbox-list-with-group{text-align:left;border-left-width:2px;border-left-style:solid}.mw-parser-output tr+tr>.navbox-abovebelow,.mw-parser-output tr+tr>.navbox-group,.mw-parser-output tr+tr>.navbox-image,.mw-parser-output tr+tr>.navbox-list{border-top:2px solid #fdfdfd}.mw-parser-output .navbox-title{background-color:#ccf}.mw-parser-output .navbox-abovebelow,.mw-parser-output .navbox-group,.mw-parser-output .navbox-subgroup .navbox-title{background-color:#ddf}.mw-parser-output .navbox-subgroup .navbox-group,.mw-parser-output .navbox-subgroup .navbox-abovebelow{background-color:#e6e6ff}.mw-parser-output .navbox-even{background-color:#f7f7f7}.mw-parser-output .navbox-odd{background-color:transparent}.mw-parser-output .navbox .hlist td dl,.mw-parser-output .navbox .hlist td ol,.mw-parser-output .navbox .hlist td ul,.mw-parser-output .navbox td.hlist dl,.mw-parser-output .navbox td.hlist ol,.mw-parser-output .navbox td.hlist ul{padding:0.125em 0}.mw-parser-output .navbox .navbar{display:block;font-size:100%}.mw-parser-output .navbox-title .navbar{float:left;text-align:left;margin-right:0.5em}body.skin--responsive .mw-parser-output .navbox-image img{max-width:none!important}@media print{body.ns-0 .mw-parser-output .navbox{display:none!important}}</style><style data-mw-deduplicate="TemplateStyles:r1129693374">.mw-parser-output .hlist dl,.mw-parser-output .hlist ol,.mw-parser-output .hlist ul{margin:0;padding:0}.mw-parser-output .hlist dd,.mw-parser-output .hlist dt,.mw-parser-output .hlist li{margin:0;display:inline}.mw-parser-output .hlist.inline,.mw-parser-output .hlist.inline dl,.mw-parser-output .hlist.inline ol,.mw-parser-output .hlist.inline ul,.mw-parser-output .hlist dl dl,.mw-parser-output .hlist dl ol,.mw-parser-output .hlist dl ul,.mw-parser-output .hlist ol dl,.mw-parser-output .hlist ol ol,.mw-parser-output .hlist ol ul,.mw-parser-output .hlist ul dl,.mw-parser-output .hlist ul ol,.mw-parser-output .hlist ul ul{display:inline}.mw-parser-output .hlist .mw-empty-li{display:none}.mw-parser-output .hlist dt::after{content:": "}.mw-parser-output .hlist dd::after,.mw-parser-output .hlist li::after{content:" · ";font-weight:bold}.mw-parser-output .hlist dd:last-child::after,.mw-parser-output .hlist dt:last-child::after,.mw-parser-output .hlist li:last-child::after{content:none}.mw-parser-output .hlist dd dd:first-child::before,.mw-parser-output .hlist dd dt:first-child::before,.mw-parser-output .hlist dd li:first-child::before,.mw-parser-output .hlist dt dd:first-child::before,.mw-parser-output .hlist dt dt:first-child::before,.mw-parser-output .hlist dt li:first-child::before,.mw-parser-output .hlist li dd:first-child::before,.mw-parser-output .hlist li dt:first-child::before,.mw-parser-output .hlist li li:first-child::before{content:" (";font-weight:normal}.mw-parser-output .hlist dd dd:last-child::after,.mw-parser-output .hlist dd dt:last-child::after,.mw-parser-output .hlist dd li:last-child::after,.mw-parser-output .hlist dt dd:last-child::after,.mw-parser-output .hlist dt dt:last-child::after,.mw-parser-output .hlist dt li:last-child::after,.mw-parser-output .hlist li dd:last-child::after,.mw-parser-output .hlist li dt:last-child::after,.mw-parser-output .hlist li li:last-child::after{content:")";font-weight:normal}.mw-parser-output .hlist ol{counter-reset:listitem}.mw-parser-output .hlist ol>li{counter-increment:listitem}.mw-parser-output .hlist ol>li::before{content:" "counter(listitem)"\a0 "}.mw-parser-output .hlist dd ol>li:first-child::before,.mw-parser-output .hlist dt ol>li:first-child::before,.mw-parser-output .hlist li ol>li:first-child::before{content:" ("counter(listitem)"\a0 "}</style><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"></div> <!-- NewPP limit report Parsed by mw‐api‐ext.eqiad.main‐58964749cd‐8s8g9 Cached time: 20241203074429 Cache expiry: 2592000 Reduced expiry: false Complications: [vary‐revision‐sha1, show‐toc] CPU time usage: 0.341 seconds Real time usage: 0.503 seconds Preprocessor visited node count: 1935/1000000 Post‐expand include size: 31466/2097152 bytes Template argument size: 881/2097152 bytes Highest expansion depth: 12/100 Expensive parser function count: 1/500 Unstrip recursion depth: 1/20 Unstrip post‐expand size: 60286/5000000 bytes Lua time usage: 0.199/10.000 seconds Lua memory usage: 6017217/52428800 bytes Number of Wikibase entities loaded: 1/400 --> <!-- Transclusion expansion time report (%,ms,calls,template) 100.00% 440.791 1 -total 44.23% 194.977 1 Template:Infobox_medical_condition_(new) 31.93% 140.765 1 Template:Reflist 28.92% 127.493 1 Template:Short_description 23.11% 101.848 6 Template:Cite_journal 17.78% 78.386 1 Template:Medical_resources 16.99% 74.901 1 Template:Navbox 14.12% 62.252 6 Template:Main_other 13.94% 61.426 1 Template:Infobox 13.15% 57.963 1 Template:SDcat --> <!-- Saved in parser cache with key enwiki:pcache:24373367:|#|:idhash:canonical and timestamp 20241203074429 and revision id 1254724998. Rendering was triggered because: api-parse --> </section></div> <!-- MobileFormatter took 0.011 seconds --><!--esi <esi:include src="/esitest-fa8a495983347898/content" /> --><noscript><img src="https://login.wikimedia.org/wiki/Special:CentralAutoLogin/start?type=1x1&amp;useformat=mobile" alt="" width="1" height="1" style="border: none; position: absolute;"></noscript> <div class="printfooter" data-nosnippet="">Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=Neuroferritinopathy&amp;oldid=1254724998">https://en.wikipedia.org/w/index.php?title=Neuroferritinopathy&amp;oldid=1254724998</a>"</div></div> </div> <div class="post-content" id="page-secondary-actions"> </div> </main> <footer class="mw-footer minerva-footer" role="contentinfo"> <a class="last-modified-bar" href="/w/index.php?title=Neuroferritinopathy&amp;action=history"> <div class="post-content last-modified-bar__content"> <span class="minerva-icon minerva-icon-size-medium minerva-icon--modified-history"></span> <span class="last-modified-bar__text modified-enhancement" data-user-name="Citation bot" data-user-gender="unknown" data-timestamp="1730458940"> <span>Last edited on 1 November 2024, at 11:02</span> </span> <span class="minerva-icon minerva-icon-size-small minerva-icon--expand"></span> </div> </a> <div class="post-content footer-content"> <div id='mw-data-after-content'> <div class="read-more-container"></div> </div> <div id="p-lang"> <h4>Languages</h4> <section> <ul id="p-variants" class="minerva-languages"></ul> <ul class="minerva-languages"><li class="interlanguage-link interwiki-ar mw-list-item"><a href="https://ar.wikipedia.org/wiki/%D8%A7%D8%B9%D8%AA%D9%84%D8%A7%D9%84_%D8%A7%D9%84%D8%A3%D8%B9%D8%B5%D8%A7%D8%A8_%D8%A7%D9%84%D8%AD%D8%AF%D9%8A%D8%AF%D9%8A" title="اعتلال الأعصاب الحديدي – Arabic" lang="ar" hreflang="ar" data-title="اعتلال الأعصاب الحديدي" data-language-autonym="العربية" data-language-local-name="Arabic" class="interlanguage-link-target"><span>العربية</span></a></li><li class="interlanguage-link interwiki-de mw-list-item"><a href="https://de.wikipedia.org/wiki/Neuroferritinopathie" title="Neuroferritinopathie – German" lang="de" hreflang="de" data-title="Neuroferritinopathie" data-language-autonym="Deutsch" data-language-local-name="German" class="interlanguage-link-target"><span>Deutsch</span></a></li><li class="interlanguage-link interwiki-fr mw-list-item"><a href="https://fr.wikipedia.org/wiki/Neuroferritinopathie" title="Neuroferritinopathie – French" lang="fr" hreflang="fr" data-title="Neuroferritinopathie" data-language-autonym="Français" data-language-local-name="French" class="interlanguage-link-target"><span>Français</span></a></li><li class="interlanguage-link interwiki-ru mw-list-item"><a href="https://ru.wikipedia.org/wiki/%D0%9D%D0%B5%D0%B9%D1%80%D0%BE%D1%84%D0%B5%D1%80%D1%80%D0%B8%D1%82%D0%B8%D0%BD%D0%BE%D0%BF%D0%B0%D1%82%D0%B8%D1%8F" title="Нейроферритинопатия – Russian" lang="ru" hreflang="ru" data-title="Нейроферритинопатия" data-language-autonym="Русский" data-language-local-name="Russian" class="interlanguage-link-target"><span>Русский</span></a></li></ul> </section> </div> <div class="minerva-footer-logo"><img src="/static/images/mobile/copyright/wikipedia-wordmark-en.svg" alt="Wikipedia" width="120" height="18" style="width: 7.5em; height: 1.125em;"/> </div> <ul id="footer-info" class="footer-info hlist hlist-separated"> <li id="footer-info-lastmod"> This page was last edited on 1 November 2024, at 11:02<span class="anonymous-show">&#160;(UTC)</span>.</li> <li id="footer-info-copyright">Content is available under <a class="external" rel="nofollow" href="https://creativecommons.org/licenses/by-sa/4.0/deed.en">CC BY-SA 4.0</a> unless otherwise noted.</li> </ul> <ul id="footer-places" class="footer-places hlist hlist-separated"> <li id="footer-places-privacy"><a href="https://foundation.wikimedia.org/wiki/Special:MyLanguage/Policy:Privacy_policy">Privacy policy</a></li> <li id="footer-places-about"><a href="/wiki/Wikipedia:About">About Wikipedia</a></li> <li id="footer-places-disclaimers"><a href="/wiki/Wikipedia:General_disclaimer">Disclaimers</a></li> <li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li> <li id="footer-places-wm-codeofconduct"><a href="https://foundation.wikimedia.org/wiki/Special:MyLanguage/Policy:Universal_Code_of_Conduct">Code of Conduct</a></li> <li id="footer-places-developers"><a href="https://developer.wikimedia.org">Developers</a></li> <li id="footer-places-statslink"><a href="https://stats.wikimedia.org/#/en.wikipedia.org">Statistics</a></li> <li id="footer-places-cookiestatement"><a href="https://foundation.wikimedia.org/wiki/Special:MyLanguage/Policy:Cookie_statement">Cookie statement</a></li> <li id="footer-places-terms-use"><a href="https://foundation.m.wikimedia.org/wiki/Special:MyLanguage/Policy:Terms_of_Use">Terms of Use</a></li> <li id="footer-places-desktop-toggle"><a id="mw-mf-display-toggle" href="//en.wikipedia.org/w/index.php?title=Neuroferritinopathy&amp;mobileaction=toggle_view_desktop" data-event-name="switch_to_desktop">Desktop</a></li> </ul> </div> </footer> </div> </div> <div class="mw-notification-area" data-mw="interface"></div> <!-- v:8.3.1 --> <script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgHostname":"mw-web.codfw.main-6dfcdd5ff5-lqzq6","wgBackendResponseTime":148,"wgPageParseReport":{"limitreport":{"cputime":"0.341","walltime":"0.503","ppvisitednodes":{"value":1935,"limit":1000000},"postexpandincludesize":{"value":31466,"limit":2097152},"templateargumentsize":{"value":881,"limit":2097152},"expansiondepth":{"value":12,"limit":100},"expensivefunctioncount":{"value":1,"limit":500},"unstrip-depth":{"value":1,"limit":20},"unstrip-size":{"value":60286,"limit":5000000},"entityaccesscount":{"value":1,"limit":400},"timingprofile":["100.00% 440.791 1 -total"," 44.23% 194.977 1 Template:Infobox_medical_condition_(new)"," 31.93% 140.765 1 Template:Reflist"," 28.92% 127.493 1 Template:Short_description"," 23.11% 101.848 6 Template:Cite_journal"," 17.78% 78.386 1 Template:Medical_resources"," 16.99% 74.901 1 Template:Navbox"," 14.12% 62.252 6 Template:Main_other"," 13.94% 61.426 1 Template:Infobox"," 13.15% 57.963 1 Template:SDcat"]},"scribunto":{"limitreport-timeusage":{"value":"0.199","limit":"10.000"},"limitreport-memusage":{"value":6017217,"limit":52428800}},"cachereport":{"origin":"mw-api-ext.eqiad.main-58964749cd-8s8g9","timestamp":"20241203074429","ttl":2592000,"transientcontent":false}}});});</script> <script type="application/ld+json">{"@context":"https:\/\/schema.org","@type":"Article","name":"Neuroferritinopathy","url":"https:\/\/en.wikipedia.org\/wiki\/Neuroferritinopathy","sameAs":"http:\/\/www.wikidata.org\/entity\/Q3338664","mainEntity":"http:\/\/www.wikidata.org\/entity\/Q3338664","author":{"@type":"Organization","name":"Contributors to Wikimedia projects"},"publisher":{"@type":"Organization","name":"Wikimedia Foundation, Inc.","logo":{"@type":"ImageObject","url":"https:\/\/www.wikimedia.org\/static\/images\/wmf-hor-googpub.png"}},"datePublished":"2009-09-17T09:51:53Z","dateModified":"2024-11-01T11:02:20Z","image":"https:\/\/upload.wikimedia.org\/wikipedia\/commons\/2\/26\/Gray745.png","headline":"Neuroferritinopathy is a late-onset type of neurodegeneration with brain iron accumulation (NBIA; see this term) characterized by progressive chorea or dystonia and subtle cognitive deficits"}</script><script>(window.NORLQ=window.NORLQ||[]).push(function(){var ns,i,p,img;ns=document.getElementsByTagName('noscript');for(i=0;i<ns.length;i++){p=ns[i].nextSibling;if(p&&p.className&&p.className.indexOf('lazy-image-placeholder')>-1){img=document.createElement('img');img.setAttribute('src',p.getAttribute('data-src'));img.setAttribute('width',p.getAttribute('data-width'));img.setAttribute('height',p.getAttribute('data-height'));img.setAttribute('alt',p.getAttribute('data-alt'));p.parentNode.replaceChild(img,p);}}});</script> </body> </html>

Pages: 1 2 3 4 5 6 7 8 9 10